Document:

EX-10.4

 Exhibit 10.4 

INVESTOR RIGHTS AND LOCK-UP AGREEMENT 

THIS INVESTOR RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”) is entered into
as of June 8, 2022, by and among Dynamics Special Purpose Corp., a Delaware corporation, (the “Company”) and the parties listed as Investors on Schedule I hereto (each, including any person or entity who hereinafter becomes a
party to this Agreement pursuant to Section 8.2, an “Investor” and collectively, the “Investors”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed
to such terms in the Business Combination Agreement (as defined below). 
 WHEREAS, the Company, Explore Merger Sub, Inc., a Delaware
corporation (“Merger Sub”) and Senti Biosciences, Inc., a Delaware corporation (“Senti”) have entered into that certain Business Combination Agreement, dated as of December 19, 2021 (as amended or supplemented
from time to time, the “Business Combination Agreement”), pursuant to which, among other things, Merger Sub will merge with and into Senti (the “Merger”), with Senti surviving as a wholly owned subsidiary of the
Company; 
 WHEREAS, the Company, Dynamics Sponsor LLC, a Delaware limited liability company (“Sponsor”), Omid Farokhzad,
Mostafa Ronaghi, Mark Afrasiabi, David Epstein, Jay Flatley, Deep Nishar, Rowan Chapman, Bob Langer and any person or entity who hereafter became or becomes a party to the Prior DYNS Agreement (as defined below) pursuant to Section 6.2 thereof
are parties to that certain Registration and Shareholder Rights Agreement, dated May 25, 2021 (the “Prior DYNS Agreement”); 

WHEREAS, the Company, the Sponsor and certain DYNS Stockholders (such certain DYNS Stockholders, the
“Non-Redemption Investors”) entered into non-redemption agreements (as amended or supplemented from time to time, the “Non-Redemption Agreements”), pursuant to which, among other things (a) such DYNS Stockholders agreed, for the benefit of DYNS, (i) to not exercise their Redemption Rights in respect of
(x) the Class A Common Stock beneficially owned by it, or (y) any other shares, capital stock or other equity interests, as applicable, of the Company, which it holds as of the Effective Time, (ii) to not, among other things,
sell, encumber or otherwise transfer such Class A Common Stock or other shares, capital stock, or equity interests, (b) the Sponsor agreed to forfeit to the Company certain Class B Common Stock which it holds, and (c) the Company
agreed to cancel such Class B Common Stock of the Sponsor and concurrently issue to the Non-Redemption Investor an equivalent number of shares of Class A Common Stock, in the case of clauses
(b) and (c) above, at or promptly following the consummation of the Merger and, in each case, on the terms and subject to the conditions therein; 

WHEREAS, Senti is party to that certain Amended and Restated Investors’ Rights Agreement, dated as of October 22, 2020, by and among
Senti and certain investors listed therein (the “Prior Senti Agreement” and together with the Prior DYNS Agreement, the “Prior Agreements”); 

WHEREAS, as of the date of this Agreement, the Sponsor holds 5,750,000 shares of Class B Common Stock of the Company (collectively, the
“Founder Shares”); 

 WHEREAS, the Founder Shares will automatically convert into Class A Common Stock at the
time of the initial Business Combination (as defined in the Prior DYNS Agreement) on a one-for-one basis, subject to adjustment, on the terms and conditions provided in
the DYNS Certificate of Incorporation; 
 WHEREAS, certain investors (“Senti Investors”) hold (a) shares of common
stock, par value $0.001 per share, of Senti (“Senti Common Stock”); (b) shares designated as “Series A Preferred Stock” (“Senti Series A Preferred Stock”); and (c) shares designated as “Series B
Preferred Stock” (“Senti Series B Preferred Stock”, and together with Senti Common Stock, Senti Series A Preferred Stock, and Senti Series B Preferred Stock, the “Senti Shares”); 

WHEREAS, the Senti Shares will be exchanged for Class A Common Stock on or about the date hereof, pursuant to the Business Combination
Agreement; 
 WHEREAS, certain Investors have subscribed to purchase shares of Class A Common Stock in the PIPE Financing (as defined
in the Business Combination Agreement) in connection with the consummation of the Merger; and 
 WHEREAS, DYNS and Senti desire to terminate
the Prior Agreements to provide for the terms and conditions included herein. 
 NOW, THEREFORE, in consideration of the mutual covenants
and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

1. DEFINITIONS. The following capitalized terms used herein have the following meanings: 

“Addendum Agreement” is defined in Section 8.2. 

“Adverse Disclosure” mean public disclosure of any material nonpublic information which, in the good faith reasonable
determination of the board of directors of the Company, (i) would be required to be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement, from and after its effective date, does not contain an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) would not be required to be made at such time but for the filing, effectiveness
or continued use of such Registration Statement; and (iii) the Company has a bona fide business purpose for not disclosing publicly and would reasonably be likely to be detrimental to the Company and its subsidiaries. 

“Agreement” is defined in the preamble to this Agreement. 

“Block Trade” means any non-marketed underwritten offering taking the form of a block
trade to financial institutions, QIBs or Institutional Accredited Investors, bought deals, over-night deals or similar transactions that do not include “road show” presentations to potential investors requiring marketing effort from
management over multiple days. 
 “Business Combination Agreement” is defined in the preamble to this Agreement. 

  
 2 

 “Business Day” means a day other than a Saturday, Sunday or other day on
which commercial banks in New York, New York are authorized or required by law to close. 
 “Class A Common
Stock” is defined in the recitals to this Agreement. 
 “Closing Date” is defined in the Business Combination
Agreement. 
 “Commission” means the Securities and Exchange Commission, or any other Federal agency then administering the
Securities Act or the Exchange Act. 
 “Company” is defined in the preamble to this Agreement. 

“Company Board” is defined in Section 3.1.1. 

“Demand Registration” is defined in Section 2.2.1. 

“Demanding Holder” is defined in Section 2.2.1. 

“DYNS Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of DYNS Special Purpose
Corp., effective as of May 25, 2021. 
 “DYNS Investors” shall mean the investors listed on Schedule I hereto,
together with any of their respective Permitted Transferees. 
 “Effectiveness Period” is defined in
Section 3.1.3. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect at the time. 
 “Form 10
Disclosure Filing Date” means the date on which the Company shall file with the Commission a Current Report on Form 8-K that includes current “Form 10 information” (within the meaning of
Rule 144) reflecting the Company’s status as an entity that is no longer an issuer described in paragraph (i)(1)(i) of Rule 144. 

“Form S-1” means a Registration Statement on Form S-1. 

“Form S-3” means a Registration Statement on Form S-3 or any similar short-form
registration that may be available at such time. 
 “Founder Shares” is defined in the recitals to this Agreement. 

“Indemnified Party” is defined in Section 4.3. 

“Indemnifying Party” is defined in Section 4.3. 

“Initiating Holder” is defined in Section 2.1.6. 

  
 3 

 “Institutional Accredited Investor” means an institutional
“accredited” investor as defined in Rule 501(a) of Regulation D under the Securities Act. 
 “Investor” is
defined in the preamble to this Agreement. 
 “Investor Indemnified Party” is defined in
Section 4.1. 
 “Lock-up Release Date” means, for
purposes of this Agreement for certain Investors as set forth on Schedule II to this agreement, (I)(i) the earliest of (A) the one year anniversary of the Closing and (B) subsequent to the Closing, if the last reported sale price of the
Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period commencing at least
150 days after the Closing, or (ii) the earliest of (A) the eighteen (18) month anniversary of the Closing and (B) subsequent to the Closing, if the last reported sale price of the Class A Common Stock equals or exceeds
$12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 consecutive trading day period commencing at least 330 days after the Closing, or (iii) the
three year anniversary of the Closing, or (II) the date upon completion of a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the public stockholders of Parent having the right to exchange
their DYNS Common Stock for cash, securities or other property. 
 “Maximum Number of Shares” is defined in
Section 2.2.4. 
 “New Registration Statement” is defined in
Section 2.1.4. 
 “New Securities” means all shares of Class A Common Stock issued in
connection with the Merger. 
 “Notices” is defined in Section 8.5. 

“Permitted Transferee” means (i) the members of an Investor’s immediate family (for purposes of this Agreement,
“immediate family” shall mean with respect to any natural person, any of the following: such person’s spouse, the siblings of such person and his or her spouse, and the direct descendants and ascendants (including adopted and
step children and parents) of such person and his or her spouses and siblings); (ii) any trust or family limited liability company or partnership for the direct or indirect benefit of an Investor or the immediate family of an Investor; (iii) if
an Investor is a trust, to the trustor or beneficiary of such trust or to the estate of a beneficiary of such trust; (iv) any officer, director, general partner, limited partner, shareholder, member, or owner of similar equity interests in an
Investor; or (v) any affiliate of an Investor. 
 “Piggy-Back Registration” is defined in
Section 2.3.1. 
 “Prior Agreements” is defined in the preamble to this Agreement. 

“Prior DYNS Agreement” is defined in the preamble to this Agreement. 

“Prior Senti Agreement” is defined in the preamble to this Agreement. 

  
 4 

 “Pro Rata” is defined in Section 2.2.4. 

“QIB” means “qualified institutional buyer” as defined in Rule 144A under the Securities Act. 

“Registrable Securities” means (i) New Securities and, for Investors other than the
Non-Redemption Investors, shares of Class A Common Stock issued in the PIPE Financing, and (ii) all shares of Class A Common Stock issued to any Investor with respect to such securities
referenced in clause (i) by way of any share split, share dividend or other distribution, recapitalization, share exchange, share reconstruction, amalgamation, contractual control arrangement or similar event. As to any particular Registrable
Securities, such securities shall cease to be Registrable Securities when: (a) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold,
transferred, disposed of or exchanged in accordance with such Registration Statement; (b) such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have
been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities Act; or (c) such securities shall have ceased to be outstanding. 

“Registration” means a registration effected by preparing and filing a registration statement or similar document in
compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective. 

“Registration Statement” means a registration statement filed by the Company with the Commission in compliance with the
Securities Act and the rules and regulations promulgated thereunder for a public offering and sale of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities (other than a
registration statement on Form S-4 or Form S-8, or their successors, or any registration statement covering only securities proposed to be issued in exchange for
securities or assets of another entity). 
 “Resale Shelf Registration Statement” is defined in
Section 2.1.1. 
 “Rule 415 Notice” is defined in Section 2.1.4. 

“SEC Guidance” is defined in Section 2.1.4. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated
thereunder, all as the same shall be in effect at the time. 
 “Senti Common Stock” is defined in the recitals to this
Agreement. 
 “Senti Investors” is defined in the recitals to this Agreement. 

“Senti Series A Preferred Stock” is defined in the recitals to this Agreement. 

“Senti Series B Preferred Stock” is defined in the recitals to this Agreement. 

  
 5 

 “Senti Shares” is defined in the recitals to this Agreement. 

“Shelf Participant” is defined in Section 2.1.6. 

“Takedown Demand” is defined in Section 2.1.6. 

“Transfer” means to (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to
purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, and
the rules and regulations of the Commission promulgated thereunder, with respect to any shares of Class A Common Stock, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of any shares of Class A Common Stock, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) publicly announce any intention to effect any transaction,
including the filing of a registration statement specified in clause (i) or (ii), other than a Registration Statement filed pursuant to this Agreement. Notwithstanding the foregoing, a Transfer shall not be deemed to include any transfer for no
consideration if the donee, trustee, heir or other transferee has agreed in writing to be bound by the same terms under this Agreement to the extent and for the duration that such terms remain in effect at the time of the Transfer. 

“Underwriter” means a securities dealer who purchases any Registrable Securities as principal in an underwritten offering and
not as part of such dealer’s market-making activities. 
 “Underwritten Demand Registration” shall mean an
underwritten public offering of Registrable Securities pursuant to a Demand Registration, as amended or supplemented, that is a fully marketed underwritten offering that requires Company management to participate in “road show”
presentations to potential investors requiring substantial marketing effort from management over multiple days, the issuance of a “comfort letter” by the Company’s auditors, and the issuance of legal opinions by the Company’s
legal counsel. 
 “Underwritten Takedown” shall mean an underwritten public offering of Registrable Securities pursuant to
the Resale Shelf Registration Statement, as amended or supplemented, that requires the issuance of a “comfort letter” by the Company’s auditors and the issuance of legal opinions by the Company’s legal counsel. 

2. REGISTRATION RIGHTS. 
 2.1 Resale
Shelf Registration Rights. 
 2.1.1 Registration Statement Covering Resale of Registrable Securities. Provided compliance by the
Investors with Section 3.4, the Company shall prepare and file or cause to be prepared and filed with the Commission, as soon as reasonably practical, but in no event later than twenty (20) calendar days following the
Closing Date, a Registration Statement on Form S-3 or its successor form, or, if the Company is ineligible to use Form S-3, a Registration Statement on Form S-1, for an offering to be made on a continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by Investors of all of the Registrable Securities then held by such Investors
that are not covered by an effective resale 

  
 6 

 
registration statement (the “Resale Shelf Registration Statement”). The Company shall use commercially reasonable efforts to cause the Resale Shelf Registration Statement to be
declared effective as soon as possible after filing, and in no event later than the earlier of (x) 60th calendar day after the Closing (or 90th
calendar day if the SEC notifies (orally or in writing, whichever is earlier) the Company that it will “review” the Resale Shelf Registration Statement) and, (y) the 5th Business
Day after the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Resale Shelf Registration Statement will not be “reviewed” or will not be subject to further review. Once effective the Company shall use
commercially reasonable efforts to keep the Resale Shelf Registration Statement continuously effective under the Securities Act at all times until the expiration of the Effectiveness Period (as defined below). In the event that the Company files a
Form S-1 pursuant to this Section 2.1, the Company shall use its commercially reasonable efforts to convert the Form S-1 to a Form S-3 promptly after the Company is eligible to use Form S-3. The Resale Shelf Registration Statement shall provide that the Registrable Securities may be sold pursuant to any
method or combination of methods legally available to, and requested by, the Investors, including the registration of the distribution to its shareholders, partners, members or other affiliates. Without limiting the foregoing, subject to any
comments from the Commission, each Registration Statement filed pursuant to this Section 2.1.1 shall include a “plan of distribution” approved by Senti Investors holding a majority of the Registrable Securities.

 2.1.2 Notification and Distribution of Materials. The Company shall promptly notify the Investors in writing of the effectiveness
of the Resale Shelf Registration Statement and shall furnish to them, without charge, such number of copies of the Resale Shelf Registration Statement (including any amendments, supplements and exhibits), the prospectus contained therein (including
each preliminary prospectus and all related amendments and supplements) and any documents incorporated by reference in the Resale Shelf Registration Statement or such other documents as the Investors may reasonably request in order to facilitate the
sale of the Registrable Securities in the manner described in the Resale Shelf Registration Statement. 
 2.1.3 Amendments and
Supplements. Subject to the provisions of Section 2.1.1 above, the Company shall promptly prepare and file with the Commission from time to time such amendments and supplements to the Resale Shelf Registration Statement
and prospectus used in connection therewith as may be necessary to keep the Resale Shelf Registration Statement effective and to comply with the provisions of the Securities Act with respect to the disposition of all the Registrable Securities
during the Effectiveness Period (as defined below). 
 2.1.4 Reduction of Shelf Offering. Notwithstanding the registration
obligations set forth in this Section 2.1, in the event the Commission informs the Company (the “Rule 415 Notice”) that all of the Registrable Securities cannot, as a result of the application of
Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i) inform each of the holders thereof and use its commercially reasonable efforts to file an amendment or amendments
to the Resale Shelf Registration Statement as required by the Commission and/or (ii) withdraw the Resale Shelf Registration Statement and file a new registration statement (a “New Registration Statement”), in either case
covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-1, Form S-3 or such other form available to register for
resale the Registrable Securities as a secondary offering; provided, however, that prior to filing such amendment or New 

  
 7 

 
Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable Securities in
accordance with any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the “SEC Guidance”), including, without limitation, Compliance and Disclosure Interpretation 612.09.
Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding
that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in writing by a holder as to its Registrable Securities, the number of
Registrable Securities to be registered on such Registration Statement will be reduced on a Pro Rata basis, subject to a determination by the Commission that certain Investors must be reduced first based on the number of Registrable Securities held
by such Investors. In the event the Company amends the Resale Shelf Registration Statement or files a New Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will use its commercially reasonable efforts to
file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on Form S-1, Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Resale Shelf Registration Statement, as amended, or the New Registration Statement. If
the Company shall not be able to register for resale all of the Registrable Securities on the Resale Shelf Registration Statement within three (3) months following the date of the Company’s receipt of the Commission’s Notice, then,
until such Resale Shelf Registration Statement is effective, each of the Senti Investors shall be entitled to demand registration rights pursuant to Section 2.2 below as long as the demand request is a proposal to sell Registrable Securities
with an aggregate market price at the time of request of not less than $5,000,000 (the “Shelf Demand Right”). Shelf Demand Rights shall not be counted as Demand Registrations under Section 2.2. 

No Investor shall be named as an “underwriter” in any Registration Statement filed pursuant to this Section 2 without the
Investor’s prior written consent; provided that if the Commission requests that an Investor be identified as a statutory underwriter in the Registration Statement, then such Investor will have the option, in its sole and absolute discretion, to
either (i) have the opportunity to withdraw from the Registration Statement upon its prompt written request to the Company, in which case the Company’s obligation to register such Investor’s Registrable Securities shall be deemed
satisfied or (ii) be included as such in the Registration Statement. Each Registration Statement (and each amendment or supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to (and shall be subject
to the approval, which shall not be unreasonably withheld or delayed, of) the Investors prior to its filing with, or other submission to, the Commission. 

2.1.5 Notice of Certain Events. The Company shall promptly notify the Investors in writing of any request by the Commission for any
amendment or supplement to, or additional information in connection with, the Resale Shelf Registration Statement required to be prepared and filed hereunder (or prospectus relating thereto). The Company shall promptly notify each Investor, or their
representatives, in writing of the filing of the Resale Shelf Registration Statement or any prospectus, amendment or supplement related thereto or any post-effective amendment to the Resale Shelf Registration Statement and the effectiveness of any
post-effective amendment. 

  
 8 

 2.1.6 Underwritten Takedown. If the Company shall receive a request (a
“Takedown Demand”) from the (i) holders of Registrable Securities with an estimated market value of at least $5,000,000 or (ii) the holders of Registrable Securities registered under the Resale Shelf Registration Statement
that own in the aggregate at least 5% of the outstanding Class A Common Stock requesting a registration of at least $5,000,000 (either an “Initiating Holder”) that the Company effect an Underwritten Takedown of all or any
portion of the requesting holder’s Registrable Securities covered under the Resale Shelf Registration Statement, then the Company shall give (x) in connection with any non-marketed underwritten
takedown offering (other than a Block Trade), at least two (2) Business Days’ notice of such Takedown Demand to each holder of Registrable Securities (other than the Initiating Holder) that is a participant in the Resale Shelf Registration
Statement (“Shelf Participant”), (y) in connection with any Block Trade initiated, notice of such Underwritten Takedown to each holder of Registrable Securities (other than the Initiating Holder) that is a Shelf Participant no later
than noon Eastern time on the Business Day prior to the requested Underwritten Takedown and (z) in connection with any marketed Underwritten Takedown, at least five (5) Business Days’ notice of such Underwritten Takedown to each
holder of Registrable Securities (other than the Initiating Holder) that is a Shelf Participant. In connection with (x) any non-marketed Underwritten Takedown initiated and (y) any marketed
Underwritten Takedown, if any Shelf Participants entitled to receive a notice pursuant to the preceding sentence request inclusion of their Registrable Securities covered by the Resale Shelf Registration Statement (by written notice to the Company,
which notice must be received by the Company no later than (A) in the case of a non-marketed Underwritten Takedown (other than a Block Trade), the Business Day following the date notice is given to such
participant, (B) in the case of a Block Trade, by 10:00 p.m. Eastern time on the date notice is given to such participant and (C) in the case of a marketed Underwritten Takedown, three (3) Business Days following the date notice is
given to such participant), the Initiating Holder and the other Shelf Participants that request inclusion of their Registrable Securities shall be entitled to sell their Registrable Securities in such offering. Thereupon the Company shall use its
commercially reasonable efforts to effect, as expeditiously as possible, the offering in such Underwritten Takedown of: 

(i) subject to the restrictions set forth in Section 2.2.4, all Registrable Securities for which the
Initiating Holder has requested such offering under Section 2.1.6, and 
 (ii) subject to the
restrictions set forth in Section 2.2.4, all other Registrable Securities that any holders of Registrable Securities covered under the Resale Registration Shelf Statement have requested the Company to offer by request
received by the Company in the requisite time period, all to the extent necessary to permit the disposition (in accordance with the intended methods thereof as aforesaid) of the Registrable Securities so to be offered. 

(a) Promptly after the expiration of the relevant time period, the Company will promptly notify all selling holders of the identities of the
other selling holders and the number of shares of Registrable Securities requested to be included therein. 

  
 9 

 (b) the Company shall only be required to effectuate, within any twelve (12) month
period, one Underwritten Takedown by each of (A) the DYNS Investors, collectively, and (B) Senti Investors, collectively. 
 2.1.7
Block Trade. If the Company shall receive a request from the holders of Registrable Securities with an estimated market value of at least $5,000,000 that the Company effect the sale of all or any portion of the Registrable Securities in a
Block Trade, then the Company shall, as expeditiously as possible, initiate the offering in such Block Trade of the Registrable Securities for which such requesting holder has requested such offering under Section 2.1.7.

 2.1.8 Selection of Underwriters. The Initiating Holder(s) shall have the right to select an Underwriter or Underwriters in
connection with such Underwritten Takedown, which Underwriter or Underwriters shall be reasonably acceptable to the Company. In connection with an Underwritten Takedown, the Company shall enter into customary agreements (including an underwriting
agreement in customary form) and take such other actions as are reasonably required in order to expedite or facilitate the disposition of the Registrable Securities in such Underwritten Takedown, including, if necessary, the engagement of a
“qualified independent underwriter” in connection with the qualification of the underwriting arrangements with the Financial Industry Regulatory Authority, Inc. 

2.1.9 Underwritten Takedowns effected pursuant to this Section 2.1 shall not be counted as Demand Registrations
effected pursuant to Section 2.2. 
 2.2 Demand Registration. 

2.2.1 Request for Registration. At any time and from time to time after the expiration of any
lock-up to which an Investor’s shares are subject, if any, provided compliance by the Investors with Section 3.4, and provided further there is not an effective Resale Shelf
Registration Statement available for the resale of all of the Registrable Securities pursuant to Section 2.1 (and subject to the right of holders to effect Underwritten Takedowns under Section 2.1), (i) DYNS Investors
who hold a majority of the Registrable Securities held by all DYNS Investors or (ii) Senti Investors who hold either a majority of the Registrable Securities held by all Senti Investors, may make a written demand for Registration under the
Securities Act of all or any portion of their Registrable Securities on Form S-1 or any similar long-form Registration or, if then available, on Form S-3. Each
registration requested pursuant to this Section 2.2.1 is referred to herein as a “Demand Registration”. Any demand for a Demand Registration shall specify the number of shares of Registrable Securities
proposed to be sold and the intended method(s) of distribution thereof. The Company will within five (5) Business Days after receiving such demand, notify all Investors that are holders of Registrable Securities of the demand, and each such
holder of Registrable Securities who wishes to include all or a portion of such holder’s Registrable Securities in the Demand Registration (each such holder including shares of Registrable Securities in such registration, a “Demanding
Holder”) shall so notify the Company within five (5) Business Days after the receipt by the holder of the notice from the Company. Upon any such request, the Demanding Holders shall be entitled to have their Registrable Securities
included in the Demand Registration, subject to Section 2.2.4 and the provisos set forth in Section 3.1.1. The Company shall not be obligated to effect: (a) more than

  
 10 

 
two (2) Demand Registration during any twelve-month period (not including any Underwritten Takedown); (b) any Demand Registration at any time there is an effective Resale Shelf Registration
Statement on file with the Commission pursuant to Section 2.1 that is not subject to a reduction of registered shares under Section 2.1.4 (and subject to the obligation to effect Underwritten
Takedowns as set forth in Section 2.1); or (c) more than two (2) Underwritten Demand Registrations in respect of all Registrable Securities held by DYNS Investors. 

2.2.2 Effective Registration. A Registration will not count as a Demand Registration until the Registration Statement filed with the
Commission with respect to such Demand Registration has been declared effective and the Company has complied with all of its obligations under this Agreement with respect thereto; provided, however, that if, after such Registration Statement has
been declared effective, the offering of Registrable Securities pursuant to a Demand Registration is interfered with by any stop order or injunction of the Commission or any other governmental agency or court, the Registration Statement with respect
to such Demand Registration will be deemed not to have been declared effective, unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of the Demanding Holders thereafter elect to continue the offering; provided, further, that the Company shall not be obligated to file a second Registration Statement until a Registration
Statement that has been filed is counted as a Demand Registration or is terminated. 
 2.2.3 Underwritten Demand Registration. If the
Demanding Holders so elect and such holders so advise the Company as part of their written demand for a Demand Registration, the offering of such Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten
Demand Registration. In such event, the right of any holder to include its Registrable Securities in such registration shall be conditioned upon such holder’s participation in such underwriting and the inclusion of such holder’s
Registrable Securities in the underwriting to the extent provided herein. All Demanding Holders proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the
Underwriter or Underwriters selected for such underwriting by the holders initiating the Demand Registration, and subject to the approval of the Company. The parties agree that, in order to be effected, any Underwritten Demand Registration must
result in aggregate proceeds to the selling shareholders of at least $5,000,000. 
 2.2.4 Reduction of Offering. If the managing
Underwriter or Underwriters for a Underwritten Demand Registration that is to be an underwritten offering advises the Company and the Demanding Holders in writing that, in such Underwriter’s or Underwriters’ opinion, the dollar amount or
number of shares of Registrable Securities which the Demanding Holders desire to sell, taken together with all other shares of Class A Common Stock or other securities which the Company desires to sell and the shares of Class A Common
Stock, if any, as to which registration has been requested pursuant to written contractual piggy-back registration rights held by other shareholders of the Company who desire to sell, exceeds the maximum dollar amount or maximum number of shares
that can be sold in such offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number of shares, as applicable,
the “Maximum Number of Shares”), then the Company shall include in such registration: (i) first, the Registrable Securities as to which Demand Registration has been requested by the Demanding Holders (pro rata in accordance
with the number of shares that each such person has 

  
 11 

 
requested be included in such registration, regardless of the number of shares held by each such person (such proportion is referred to herein as “Pro Rata”)) that can be sold
without exceeding the Maximum Number of Shares; (ii) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (i), the shares of Class A Common Stock or other securities that the Company
desires to sell that can be sold without exceeding the Maximum Number of Shares; and (iii) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (i) and (ii), any shares of Class A
Common Stock or other securities for the account of other persons that the Company is obligated to register pursuant to written contractual arrangements with such persons, as to which “piggy-back” registration has been requested by the
holders thereof that can be sold without exceeding the Maximum Number of Shares. 
 2.2.5 Withdrawal. A Demanding Holder shall have
the right to withdraw all or any portion of its Registrable Securities included in an Underwritten Demand Registration pursuant to this Section 2.2 for any reason or no reason whatsoever upon written notice to the Company
and the Underwriter or Underwriters of its intention to withdraw from such Underwritten Demand Registration prior to the pricing of such Underwritten Demand Registration; provided, however, that such withdrawn amount shall still be considered an
Underwritten Demand Registration. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the registration expenses incurred in connection with an Underwritten Demand Registration prior to its withdrawal
under this Section 2.2.5.
 2.3 Piggy-Back Registration. 

2.3.1 Piggy-Back Rights. If the Company proposes to file a Registration Statement under the Securities Act with respect to an offering
of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own account or for shareholders of the Company for their account (or by the Company and by
shareholders of the Company including, without limitation, pursuant to Section 2.2.1), other than a Registration Statement (i) filed in connection with any employee stock option, employee stock purchase, or other
benefit plan, (ii) for an exchange offer or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that is convertible into equity securities of the Company, (iv) for a dividend
reinvestment plan, (v) effected pursuant to Section 2.1 or 2.2 (which, for the avoidance of doubt, is addressed in and subject to the rights set forth therein), then the Company shall (x) give written
notice of such proposed filing to the holders of Registrable Securities with respect to shares not subject to any lock-up, as soon as practicable but in no event less than ten (10) days before the
anticipated filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, of the
offering, and (y) offer to the holders of Registrable Securities in such notice the opportunity to register the sale of such number of shares of Registrable Securities as such holders may request in writing within five (5) Business Days
following receipt of such notice (a “Piggy-Back Registration”). The foregoing rights shall not be available to any Investor at such time as (i) there is an effective Resale Shelf Registration Statement available for the resale
of the Registrable Securities pursuant to Section 2.1 (which, for the avoidance of doubt, is addressed in and subject to the rights set forth in, Section 2.1 and

  
 12 

 
2.2 hereof) and there was no reduction in registered shares as set forth in Section 2.1.4 or (ii) such Registration is solely to be used for the offering of
securities by the Company for its own account. The Company shall cause such Registrable Securities to be included in such registration, provided compliance by the Investors with Section 3.4, and the Company shall use its
commercially reasonable efforts to cause the managing Underwriter or Underwriters of a proposed underwritten offering to permit the Registrable Securities requested to be included in a Piggy-Back Registration on the same terms and conditions as any
similar securities of the Company and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All holders of Registrable Securities proposing to distribute their
securities through a Piggy-Back Registration that involves an Underwriter or Underwriters shall enter into an underwriting agreement in customary form with the Underwriter or Underwriters selected for such Piggy-Back Registration. 

2.3.2 Reduction of Offering. If the managing Underwriter or Underwriters for a Piggy-Back Registration that is to be an underwritten
offering advises the Company and the holders of Registrable Securities in writing that the dollar amount or number of shares of Class A Common Stock which the Company desires to sell, taken together with shares of Class A Common Stock, if
any, as to which registration has been demanded pursuant to written contractual arrangements with persons other than the holders of Registrable Securities hereunder and the Registrable Securities as to which registration has been requested under
this Section 2.3, exceeds the Maximum Number of Shares, then the Company shall include in any such registration: 

(a) If the registration is undertaken for the Company’s account: (A) first, the shares of Class A Common Stock or other
securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Shares; and (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of
Class A Common Stock or other securities, if any, comprised of Registrable Securities, as to which registration has been requested pursuant to the terms hereof, that can be sold without exceeding the Maximum Number of Shares, Pro Rata; and
(C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B), the shares of Class A Common Stock or other securities for the account of other persons that the Company is
obligated to register pursuant to written contractual piggy-back registration rights with such persons and that can be sold without exceeding the Maximum Number of Shares; and 

(b) If the registration is a “demand” registration undertaken at the demand of persons other than either the holders of Registrable
Securities or the Company (other than as provided in Section 2.2 which, for the avoidance of doubt, is addressed in and subject to the rights set forth in, Section 2.2 hereof), (A) first, the shares of Class A Common Stock or other
securities for the account of the demanding persons that can be sold without exceeding the Maximum Number of Shares; (B) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (A), the shares of
Class A Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Shares; (C) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing
clauses (A) and (B), the shares of Class A Common Stock or other securities, if any, comprised of Registrable Securities, Pro Rata, as to which registration has been 

  
 13 

 
requested pursuant to the terms hereof, that can be sold without exceeding the Maximum Number of Shares; and (D) fourth, to the extent that the Maximum Number of Shares has not been reached
under the foregoing clauses (A), (B) and (C), the shares of Class A Common Stock or other securities for the account of other persons that the Company is obligated to register pursuant to written contractual arrangements with such persons, that
can be sold without exceeding the Maximum Number of Shares. 
 2.3.3 Withdrawal. Any holder of Registrable Securities may elect to
withdraw such holder’s request for inclusion of Registrable Securities in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the Registration Statement, if such offering
is pursuant to a Demand Registration, or prior to the public announcement of the offering, if such offering is pursuant to an Underwritten Takedown. The Company (whether on its own determination or as the result of a withdrawal by persons making a
demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration Statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the
holders of Registrable Securities in connection with such Piggy-Back Registration as provided in Section 3.3. 

2.3.4 Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.3 hereof
shall not be counted as a Registration pursuant to a Demand registered effected under Section 2.2 hereof. 
 3. REGISTRATION PROCEDURES. 

3.1 Filings; Information. Whenever the Company is required to effect the registration of any Registrable Securities pursuant to
Section 2, the Company shall use its commercially reasonable efforts to effect the registration and sale of such Registrable Securities in accordance with the intended method(s) of distribution thereof as expeditiously as
reasonably possible, and in connection with any such request: 
 3.1.1 Filing Registration Statement. The Company shall use its
commercially reasonable efforts to, as expeditiously as possible after receipt of a request for a Demand Registration pursuant to Section 2.1, prepare and file with the Commission a Registration Statement on any form for
which the Company then qualifies or which counsel for the Company shall deem appropriate and which form shall be available for the sale of all Registrable Securities to be registered thereunder in accordance with the intended method(s) of
distribution thereof, and shall use its commercially reasonable efforts to cause such Registration Statement to become effective and use its commercially reasonable efforts to keep it effective for the Effectiveness Period (as defined below);
provided, however, that the Company shall have the right to defer any Demand Registration for up to forty-five (45) days, and any Piggy-Back Registration for such period as may be applicable to deferment of any Demand Registration to which such
Piggy-Back Registration relates, in each case if the Company shall furnish to the holders a certificate signed by the Company stating that, in the good faith judgment of the Board of Directors of the Company (the “Company Board”),
it would require the Company to make an Adverse Disclosure; provided, further, however, that the Company shall not have the right to exercise the right set forth in the immediately preceding proviso twice, or for more than sixty (60) total
calendar days in any 360-day period. 

  
 14 

 3.1.2 Copies. The Company shall, prior to filing a Registration Statement or
prospectus, or any amendment or supplement thereto, furnish without charge to the holders of Registrable Securities included in such registration, and such holders’ legal counsel, copies of such Registration Statement as proposed to be filed,
each amendment and supplement to such Registration Statement (in each case, including all exhibits thereto and documents incorporated by reference therein), the prospectus included in such Registration Statement (including each preliminary
prospectus), and such other documents as the holders of Registrable Securities included in such registration or legal counsel for any such holders may request in order to facilitate the disposition of the Registrable Securities owned by such
holders. 
 3.1.3 Amendments and Supplements. The Company shall prepare and file with the Commission such amendments, including
post-effective amendments, and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement effective and in compliance with the provisions of the Securities Act
until the date on which all Registrable Securities and other securities covered by such Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such Registration Statement or such
securities have been withdrawn (the “Effectiveness Period”). 
 3.1.4 Notification. After the filing of a
Registration Statement, the Company shall promptly, and in no event more than two (2) Business Days after such filing, notify the holders of Registrable Securities included in such Registration Statement of such filing, and shall further notify
such holders promptly and confirm such advice in writing in all events within two (2) Business Days of the occurrence of any of the following: (i) when such Registration Statement becomes effective; (ii) when any post-effective
amendment to such Registration Statement becomes effective; (iii) the issuance or threatened issuance by the Commission of any stop order (and the Company shall take all actions required to prevent the entry of such stop order or to remove it
if entered); and (iv) any request by the Commission for any amendment or supplement to such Registration Statement or any prospectus relating thereto or for additional information or of the occurrence of an event requiring the preparation of a
supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of the securities covered by such Registration Statement, such prospectus will not contain an untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein not misleading, and promptly make available to the holders of Registrable Securities included in such Registration Statement any such supplement or amendment;
except that before filing with the Commission a Registration Statement or prospectus or any amendment or supplement thereto, including documents incorporated by reference, the Company shall furnish to the holders of Registrable Securities included
in such Registration Statement and to the legal counsel for any such holders, copies of all such documents proposed to be filed sufficiently in advance of filing to provide such holders and legal counsel with a reasonable opportunity to review such
documents and comment thereon. 

  
 15 

 3.1.5 Securities Laws Compliance. The Company shall use its commercially reasonable
efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the holders of Registrable Securities included
in such Registration Statement (in light of their intended plan of distribution) may reasonably request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or
approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the holders of Registrable Securities
included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it
would not otherwise be required to qualify but for this paragraph or subject itself to taxation in any such jurisdiction. 
 3.1.6
Agreements for Disposition. The Company shall enter into customary agreements (including, if applicable, an underwriting agreement in customary form) and take such other actions as are reasonably required in order to expedite or facilitate
the disposition of such Registrable Securities. The representations, warranties and covenants of the Company in any underwriting agreement which are made to or for the benefit of any Underwriters, to the extent applicable, shall also be made to and
for the benefit of the holders of Registrable Securities included in such registration statement, and the representations, warranties and covenants of the holders of Registrable Securities included in such registration statement in any underwriting
agreement which are made to or for the benefit of any Underwriters, to the extent applicable, shall also be made to and for the benefit of the Company. 

3.1.7 Comfort Letter. In the event of an Underwritten Takedown or an Underwritten Demand Registration, the Company shall obtain a
“cold comfort” letter from the Company’s independent registered public accountants in the event of an underwritten offering, and a customary “bring-down” thereof, in customary form and covering such matters of the type
customarily covered by “cold comfort” letters, as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the
participating holders. For the avoidance of doubt, this Section 3.1.7 shall not apply to any Block Trade. 
 3.1.8 Opinions and
Negative Assurance Letters. In the event of an Underwritten Takedown or an Underwritten Demand Registration, on the date the Registrable Securities are delivered for sale pursuant to any Registration, the Company shall obtain an opinion and
negative assurances letter, each dated such date, of one (1) counsel representing the Company for the purposes of such Registration, including an opinion of local counsel if applicable, addressed to the holders, the placement agent or sales
agent, if any, and the Underwriters, if any, covering such legal matters with respect to such Registration in respect of which such opinion is being given as the holders, placement agent, sales agent, or Underwriter may reasonably request and as are
customarily included in such opinions, and reasonably satisfactory to a majority in interest of the participating holders. For the avoidance of doubt, this Section 3.1.8 shall not apply to any Block Trade. 

3.1.9 Cooperation. The principal executive officer of the Company, the principal financial officer of the Company, the principal
accounting officer of the Company and all other officers and members of the management of the Company shall cooperate fully in any offering of Registrable Securities hereunder, which cooperation shall include, without limitation, the preparation of
the Registration Statement with respect to such offering, the preparation of a comfort letter, if applicable, and all other offering materials and related documents, and participation in meetings with Underwriters, attorneys, accountants and
potential investors. 

  
 16 

 3.1.10 Transfer Agent. The Company shall provide and maintain a transfer agent and
registrar for the Registrable Securities. 
 3.1.11 Records. Upon execution of confidentiality agreements, the Company shall make
available for inspection by the holders of Registrable Securities included in such Registration Statement, any Underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other professional
retained by any holder of Registrable Securities included in such Registration Statement or any Underwriter, all financial and other records, pertinent corporate documents and properties of the Company, as shall be necessary to enable them to
exercise their due diligence responsibility, and cause the Company’s officers, directors and employees to supply all information requested by any of them in connection with such Registration Statement. 

3.1.12 Earnings Statement. The Company shall comply with all applicable rules and regulations of the Commission and the Securities Act,
and make available to its shareholders, as soon as practicable, an earnings statement covering a period of twelve (12) months, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158
thereunder. 
 3.1.13 Road Show. If an offering pursuant to this Agreement is conducted as an Underwritten Takedown or Underwritten
Demand Registration and involves Registrable Securities with an aggregate offering price (before deduction of underwriting discounts) is expected to exceed $10,000,000, the Company shall use its reasonable best efforts to make available senior
executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in such offering. 

3.1.14 Listing. The Company shall use its commercially reasonable efforts to cause all Registrable Securities included in any
Registration Statement to be listed on such exchanges or otherwise designated for trading in the same manner as similar securities issued by the Company are then listed or designated. 

3.2 Obligation to Suspend Distribution. Upon receipt of any notice from the Company of the happening of any event of the kind described
in Section 3.1.4(iv), or, upon any suspension by the Company, pursuant to a good faith reasonable determination of the board of directors of the Company that the offer or sale of Registrable Securities would require the
Company to disclose Adverse Disclosure, each holder of Registrable Securities included in any registration shall immediately discontinue disposition of such Registrable Securities pursuant to the Registration Statement covering such Registrable
Securities until such holder receives the supplemented or amended prospectus contemplated by Section 3.1.4(iv) or the restriction on the ability of “insiders” to transact in the Company’s securities is
removed, as applicable, and, if so directed by the Company, each such holder will deliver to the Company or destroy all copies, other than permanent file copies then in such holder’s possession, of the most recent prospectus covering such
Registrable Securities at the time of receipt of such notice. The foregoing right to delay or suspend may be exercised by the Company for no longer than sixty (60) days in any consecutive 12-month period.

  
 17 

 3.3 Registration Expenses. The Company shall bear all costs and expenses incurred in
connection with the Resale Shelf Registration Statement pursuant to Section 2.1, any Demand Registration pursuant to Section 2.2.1, any Underwritten Takedown pursuant to
Section 2.1.6, any Block Trade pursuant to Section 2.1.7 (other than expenses set forth below in clause (ix) of this Section 3.3), any Piggy-Back Registration
pursuant to Section 2.3, and all expenses incurred in performing or complying with its other obligations under this Agreement, whether or not the Registration Statement becomes effective, including, without limitation:
(i) all registration and filing fees; (ii) fees and expenses of compliance with securities or “blue sky” laws (including fees and disbursements of counsel in connection with blue sky qualifications of the Registrable Securities);
(iii) printing expenses; (iv) the Company’s internal expenses (including, without limitation, all salaries and expenses of its officers and employees); (v) the fees and expenses incurred in connection with the listing of the Registrable
Securities as required by Section 3.1.12; (vi) Financial Industry Regulatory Authority fees; (vii) fees and disbursements of counsel for the Company and fees and expenses for independent certified public accountants
retained by the Company; (viii) the fees and expenses of any special experts retained by the Company in connection with such registration; and (ix) the reasonable fees and expenses of one legal counsel selected by the holders of a majority-in-interest of the Registrable Securities included in such registration. The Company shall have no obligation to pay any underwriting discounts or selling commissions
attributable to the Registrable Securities being sold by the holders thereof, which underwriting discounts or selling commissions shall be borne by such holders, but the Company shall pay any underwriting discounts or selling commissions
attributable to the securities it sells for its own account. 
 3.4 Information. The holders of Registrable Securities shall promptly
provide such information as may reasonably be requested by the Company, or the managing Underwriter, if any, in connection with the preparation of any Registration Statement, including amendments and supplements thereto, in order to effect the
registration of any Registrable Securities under the Securities Act and in connection with the Company’s obligation to comply with Federal and applicable state securities laws. 

3.5 Other Obligations. 

3.5.1 At any time and from time to time after the expiration of any lock-up to which such shares are
subject, if any, in connection with a sale or transfer of Registrable Securities exempt from registration under the Securities Act or through any broker-dealer transactions described in the plan of distribution set forth within any prospectus and
pursuant to the Registration Statement of which such prospectus forms a part, the Company shall, subject to the receipt of customary documentation required from the applicable holders in connection therewith, (i) promptly instruct its transfer
agent to remove any restrictive legends applicable to the Registrable Securities being sold or transferred and (ii) cause its legal counsel to deliver the necessary legal opinions, if any, to the transfer agent in connection with the
instruction under subclause (i). In addition, the Company shall cooperate reasonably with, and take such customary actions as may reasonably be requested by such holders in connection with the aforementioned sales or transfers. 

  
 18 

 3.5.2 The stock certificates evidencing the Registrable Securities (and/or book entries
representing the Registrable Securities) held by each Investor shall not contain or be subject to any legend restricting the transfer thereof (and the Registrable Securities shall not be subject to any stop transfer or similar instructions or
notations): (A) while a Registration Statement covering the sale or resale of such securities is effective under the Securities Act, or (B) if such Investor provides customary paperwork to the effect that it has sold such shares pursuant to
Rule 144, or (C) if such Registrable Securities are eligible for sale under Rule 144(b)(1) as set forth in customary non-affiliate paperwork provided by such Investor, or (D) if at any time on or
after the date that is one year after the Form 10 Disclosure Filing Date such Investor certifies that it is not an affiliate of the Company and that such Investor’s holding period for purposes of Rule 144 in respect of such Registrable
Securities is at least six (6) months, or (E) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) as determined in
good faith by counsel to the Company or set forth in a legal opinion delivered by nationally recognized counsel to the Investor (collectively, the “Unrestricted Conditions”). The Company agrees that following the date that the
Resale Shelf Registration Statement has been declared effective by the Commission or at such time as any of the Unrestricted Conditions is met or such legend is otherwise no longer required it will, no later than two (2) Business Days following
the delivery by an Investor to the Company or its transfer agent of a certificate representing any Registrable Securities, issued with a restrictive legend, (or, in the case of Registrable Securities represented by book entries, delivery by an
Investor to the Company or its transfer agent of a legend removal request) deliver or cause to be delivered to such Investor a certificate or, at the request of such Investor, deliver or cause to be delivered such Registrable Securities to such
Investor by crediting the account of such Investor’s prime broker with DTC through its Deposit/Withdrawal at Custodian (DWAC) system, in each case, free from all restrictive and other legends and stop transfer or similar instructions or
notations. If any of the Unrestricted Conditions is met at the time of issuance of any Registrable Securities (e.g., upon exercise of warrants), then such securities shall be issued free of all legends. Each Investor shall have the right to pursue
any remedies available to it hereunder, or otherwise at law or in equity, including a decree of specific performance and/or injunctive relief, with respect to the Company’s failure to timely deliver shares of Class A Common Stock without
legend as required pursuant to the terms hereof. 
 3.5.3 As long as Registrable Securities remain outstanding the Company shall
(a) cause the Class A Common Stock to be eligible for clearing through DTC, through its DWAC system; (b) be eligible and participating in the Direct Registration System (DRS) of DTC with respect to the Class A Common Stock;
(c) ensure that the transfer agent for the Class A Common Stock is a participant in, and that the Class A Common Stock is eligible for transfer pursuant to, DTC’s Fast Automated Securities Transfer Program (or successor thereto);
and (d) use its reasonable best efforts to cause the Class A Common Stock to not at any time be subject to any DTC “chill,” “freeze” or similar restriction with respect to any DTC services, including the clearing of
shares of Common Stock through DTC, and, in the event the Class A Common Stock becomes subject to any DTC “chill,” “freeze” or similar restriction with respect to any DTC services, use its reasonable best efforts to cause
any such “chill,” “freeze” or similar restriction to be removed at the earliest possible time. 

  
 19 

	4.	 INDEMNIFICATION AND CONTRIBUTION. 

4.1 Indemnification by the Company. The Company agrees to indemnify and hold harmless, to the fullest extent permitted by law, each
Investor and each other holder of Registrable Securities, and each of their respective officers, employees, affiliates, directors, partners, members, attorneys and agents, and each person, if any, who controls an Investor and each other holder of
Registrable Securities (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) (each, an “Investor Indemnified Party”), from and against any expenses, losses, judgments, claims, damages
or liabilities, whether joint or several, (including reasonable and documented costs of investigation and legal expenses and any indemnity and contribution payments made to underwriters) arising out of or based upon any untrue statement (or
allegedly untrue statement) of a material fact contained in any Registration Statement under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus
contained in the Registration Statement, or any amendment or supplement to such Registration Statement, or arising out of or based upon any omission (or alleged omission) to state a material fact required to be stated therein or necessary to make
the statements therein not misleading, or any violation by the Company of the Securities Act or any rule or regulation promulgated thereunder applicable to the Company and relating to action or inaction required of the Company in connection with any
such registration; and the Company shall promptly reimburse the Investor Indemnified Party for any legal and any other expenses reasonably incurred by such Investor Indemnified Party in connection with investigating and defending any such expense,
loss, judgment, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case to the extent that any such expense, loss, claim, damage or liability is finally judicially determined to have
arisen out of or resulted from any untrue statement or allegedly untrue statement or omission or alleged omission made in such Registration Statement, preliminary prospectus, final prospectus, or summary prospectus, or any such amendment or
supplement, in reliance upon and in conformity with information furnished to the Company, in writing, by such selling holder expressly for use therein or to the extent related to any selling holder’s violation of the federal securities laws
(including Regulation M) or failure to sell the Registrable Securities in accordance with the plan of distribution contained in the prospectus. 

4.2 Indemnification by Holders of Registrable Securities. Each selling holder of Registrable Securities will, in the event that any
Registration is being effected under the Securities Act pursuant to this Agreement of any Registrable Securities held by such selling holder, indemnify and hold harmless to the fullest extent permitted by law the Company, each of its directors and
officers, and each other selling holder of Registrable Securities and each other person, if any, who controls such other selling holder within the meaning of the Securities Act, against any losses, claims, judgments, damages or liabilities, only
insofar as such losses, claims, judgments, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or allegedly untrue statement of a material fact contained in any Registration Statement
under which the sale of such Registrable Securities was registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in the Registration Statement, or any amendment or supplement to the
Registration Statement, or arise out of or are based upon any omission or the alleged omission to state a material fact required to be stated therein or necessary to make the statement therein not misleading, if the statement or omission was made
expressly in reliance upon and in conformity with information furnished in writing to the Company by such selling holder in writing expressly for use therein, or (ii) such selling holder’s failure to sell the Registrable Securities in
accordance 

  
 20 

 
with the plan of distribution contained in the prospectus, and shall reimburse the Company, its directors and officers, and each other selling holder or controlling person for any legal or other
expenses reasonably incurred by any of them in connection with investigation or defending any such loss, claim, damage, liability or action. Each selling holder’s indemnification obligations hereunder shall be several and not joint and shall be
limited to the amount of any net proceeds actually received by such selling holder upon the sale of Registrable Securities giving rise to such indemnification obligations. 

4.3 Conduct of Indemnification Proceedings. Promptly after receipt by any person of any notice of any loss, claim, damage or liability
or any action in respect of which indemnity may be sought pursuant to Sections 4.1 or 4.2, such person (the “Indemnified Party”) shall, if a claim in respect thereof is to be made against any other person for
indemnification hereunder, notify such other person (the “Indemnifying Party”) in writing of the loss, claim, judgment, damage, liability or action; provided, however, that the failure by the Indemnified Party to notify the
Indemnifying Party shall not relieve the Indemnifying Party from any liability which the Indemnifying Party may have to such Indemnified Party hereunder, except and solely to the extent the Indemnifying Party is actually prejudiced by such failure.
If the Indemnified Party is seeking indemnification with respect to any claim or action brought against the Indemnified Party, then the Indemnifying Party shall be entitled to participate in such claim or action, and, to the extent that it wishes,
jointly with all other Indemnifying Parties, to assume control of the defense thereof with counsel satisfactory to the Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume control of the
defense of such claim or action, the Indemnifying Party shall not be liable to the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of
investigation; provided, however, that in any action in which both the Indemnified Party and the Indemnifying Party are named as defendants, the Indemnified Party shall have the right to employ separate counsel (but no more than one such separate
counsel, which counsel is reasonably acceptable to the Indemnifying Party) to represent the Indemnified Party and its controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the
Indemnified Party against the Indemnifying Party, with the fees and expenses of such counsel to be paid by such Indemnifying Party if, based upon the written opinion of counsel of such Indemnified Party, representation of both parties by the same
counsel would be inappropriate due to actual or potential differing interests between them. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, consent to entry of judgment or effect any settlement of any claim
or pending or threatened proceeding in respect of which the Indemnified Party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such judgment or settlement includes an unconditional
release of such Indemnified Party from all liability arising out of such claim or proceeding. 
 4.4 Contribution. 

4.4.1 If the indemnification provided for in the foregoing Sections 4.1, 4.2 and 4.3 is unavailable to any Indemnified
Party in respect of any loss, claim, damage, liability or action referred to herein, then each such Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a
result of such loss, claim, damage, liability or action in such proportion as is appropriate to 

  
 21 

 
reflect the relative fault of the Indemnified Parties and the Indemnifying Parties in connection with the actions or omissions which resulted in such loss, claim, damage, liability or action, as
well as any other relevant equitable considerations. The relative fault of any Indemnified Party and any Indemnifying Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or
the omission or alleged omission to state a material fact relates to information supplied by such Indemnified Party or such Indemnifying Party and the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. 
 4.4.2 The parties hereto agree that it would not be just and equitable if contribution pursuant to
this Section 4.4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in Section 4.4.1. 

4.4.3 The amount paid or payable by an Indemnified Party as a result of any loss, claim, damage, liability or action referred to in the
immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 4.4, no holder of Registrable Securities shall be required to contribute any amount in excess of the dollar amount of the net proceeds (after payment of any underwriting fees,
discounts, commissions or taxes) actually received by such holder from the sale of Registrable Securities which gave rise to such contribution obligation. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 
  

	5.	 UNDERWRITING AND DISTRIBUTION. 

5.1 Rule 144. The Company covenants that it shall timely file any reports required to be filed by it under the Securities Act and the
Exchange Act and shall take such further action as the holders of Registrable Securities may reasonably request, all to the extent required from time to time to enable such holders to sell Registrable Securities without registration under the
Securities Act within the limitation of the exemptions provided by Rule 144 under the Securities Act, as such Rules may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission. Upon reasonable prior
written request, the Company shall deliver to the Investors a customary written statement as to whether it has complied with such requirements. 
  

	6.	 LOCK-UP AGREEMENTS. 

6.1 Investor Lock-Up. Without limiting the terms of any other Ancillary Document or any other
contract, agreement or understanding entered into by any Investor, each Investor agrees that it shall not Transfer any shares of Class A Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for
shares of Class A Common Stock (including New Securities) until the Lock-Up Release Date; provided, however, that the foregoing restrictions shall (i) not apply to any shares of
Class A Common Stock 

  
 22 

 
purchased by an Investor in the PIPE Financing, and (ii) with respect to the Non-Redemption Investors, only apply to shares of Class A Common
Stock received by the Non-Redemption Investors pursuant to the Non-Redemption Agreements. The foregoing restriction is expressly agreed to preclude each Investor
from engaging in any hedging or other transaction which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of such Investor’s shares of Class A Common Stock even if such shares of
Class A Common Stock would be disposed of by someone other than the undersigned until the Lock-Up Release Date. Such prohibited hedging or other transactions would include without limitation any short
sale or any purchase, sale or grant of any right (including, without limitation, any put or call option) with respect to any of the Investor’s shares of Class A Common Stock or with respect to any security that includes, relates to, or
derives any significant part of its value from such shares of Class A Common Stock. The foregoing restrictions shall not apply to Transfers made: (i) pursuant to a bona fide gift or charitable contribution; (ii) by
will or intestate succession upon the death of an Investor; (iii) to any Permitted Transferee; (iv) pursuant to a court order or settlement agreement related to the distribution of assets in connection with the dissolution of marriage or
civil union; or (v) in the case of any Investor that is not a natural person, pro rata to the direct or indirect partners, members or shareholders of an Investor or any related investment funds or vehicles controlled or managed by such persons
or their respective affiliates in connection with the liquidation or dissolution thereof; or (vi) in the event of the Company’s completion of a liquidation, merger, share exchange or other similar transaction which results in all of its
shareholders having the right to exchange their shares of Class A Common Stock for cash, securities or other property; provided that in the case of (i) through (vi), the recipient of such Transfer must enter into a written agreement
agreeing to be bound by the terms of this Agreement in form and substance reasonably satisfactory to the Company, including the transfer restrictions set forth in this Section 6.1. 

The foregoing notwithstanding, to the extent any Investor is granted a release or waiver from the restrictions contained in this Section 6 prior to the
expiration of the Lock-Up Release Date, then all Investors shall be automatically granted a release or waiver from the restrictions contained in this Section 6 to the same extent, on substantially the
same terms as and on a pro rata basis with, the Investor to which such release or waiver is granted. 
  

	7.	 RESERVED. 

  

	8.	 MISCELLANEOUS. 

8.1 Other Registration Rights and Arrangements. The Company represents and warrants that no person, other than a holder of the
Registrable Securities and the investors of the PIPE Financing and Convertible Financing has any right to require the Company to register any of the Company’s capital stock for sale or to include the Company’s capital stock in any
registration filed by the Company for the sale of capital stock for its own account or for the account of any other person. The parties hereby terminate the Prior Agreements, each of which shall be of no further force and effect and is hereby
superseded and replaced in its entirety by this Agreement. The Company shall not hereafter enter into any agreement with respect to its securities which is inconsistent with or violates the rights granted to the holders of Registrable Securities in
this Agreement and in the event of any conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail. 

  
 23 

 8.2 Assignment; No Third-Party Beneficiaries. This Agreement and the rights, duties
and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part. This Agreement and the rights, duties and obligations of the holders of Registrable Securities hereunder may be freely assigned or
delegated by such holder of Registrable Securities in conjunction with and to the extent of any permitted transfer of Registrable Securities by any such holder to a Permitted Transferee. This Agreement and the provisions hereof shall be binding upon
and shall inure to the benefit of each of the parties hereto and their respective successors and assigns and the holders of Registrable Securities and their respective successors and permitted assigns. This Agreement is not intended to confer any
rights or benefits on any persons that are not party hereto other than as expressly set forth in Section 4 and this Section 8.2. The rights of a holder of Registrable Securities under this
Agreement may be transferred by such a holder to a transferee who acquires or holds Registrable Securities; provided, however, that such transferee has executed and delivered to the Company a properly completed agreement to be bound by the terms of
this Agreement substantially in form attached hereto as Exhibit A (an “Addendum Agreement”), and the transferor shall have delivered to the Company no later than fifteen (15) days following the date of the transfer, written
notification of such transfer setting forth the name of the transferor, the name and address of the transferee, and the number of Registrable Securities so transferred. The execution of an Addendum Agreement shall constitute a permitted amendment of
this Agreement. 
 8.3 Amendments and Modifications. Upon the written consent of the Company and the Investors of at least a majority
in interest of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or
modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects an Investor, solely in his, her or its capacity as a holder of the shares of capital stock of the Company, in a manner that
is materially different from other Investors (in such capacity) shall require the consent of such Investor so affected; provided, further, however, that any waiver, amendment or repeal of the restrictions set forth in Section 6.1 (or of this
Section 8.3 in respect of this proviso) shall require the prior written consent of the Sponsor. No course of dealing between any Investor or the Company and any other party hereto or any failure or delay on the part of an Investor or the
Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Investor or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall
operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party. 
 8.4 Term. This
Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which there shall be no Registrable Securities outstanding; provided further that with respect to any Investor,
such Investor will have no rights under this Agreement and all obligations of the Company to such Investor under this Agreement shall terminate upon the earlier of (x) the date at least one year after the date hereof that such Investor ceases
to hold at least 1 % of the Registrable Securities outstanding on the date hereof or (y) if such Investor is a director or an executive officer of the Company, the date such Investor no longer serves as a director or an executive officer
of the Company; provided, however, that such termination as to an Investors shall not apply to the following provisions until such Investor no longer holds any Registrable Securities: Sections 3.1.4, 3.1.5, 3.1.10,
3.1.12, 3.1.14, 3.2, 3.3, 3.4, 3.5, 7.3, 8.3, 8.5 and Articles IV and V. Notwithstanding the foregoing, the piggy-back registration rights provided for in
Section 2.3 of this Agreement shall terminate no later than the third anniversary of the date of this Agreement. 

  
 24 

 8.5 Notices. All notices, demands, requests, consents, approvals or other
communications (collectively, “Notices”) required or permitted to be given hereunder or which are given with respect to this Agreement shall be in writing and shall be personally served, delivered by reputable air courier service
with charges prepaid, or transmitted by facsimile or email, addressed as set forth below, or to such other address as such party shall have specified most recently by written notice. Notice shall be deemed given (i) on the date of service or
transmission if personally served or transmitted by email, or facsimile; provided, that if such service or transmission is not on a Business Day or is after normal business hours, then such notice shall be deemed given on the next Business Day or
(ii) one Business Day after being deposited with a reputable courier service with an order for next-day delivery, to the parties as follows: 

If to the Company: 
 Senti
Biosciences, Inc. 
 2 Corporate Drive, 1st Floor 

South San Francisco, CA 94080 

Attn: Timothy Lu 
 Email: 

with a copy to: 
 Goodwin Procter
LLP 
 100 Northern Avenue 

Boston, MA 02210 
 Attn: Jocelyn
Arel 
 Michael Patrone 

Email: 
 If to DYNS: 

2875 El Camino Real 
 Redwood
City, CA 94061 
 Attn: Mostafa Ronaghi, Chief Executive Officer 

Email: 
 with a copy to: 

Davis Polk & Wardwell LLP 

450 Lexington Avenue 
 New York,
NY 10017 
 Attn: Alan Denenberg 

Oliver Smith 
 Email: 

  
 25 

 If to an Investor, to the address set forth under such Investor’s signature to this
Agreement or to such Investor’s address as found in the Company’s books and records. 
 8.6 Severability. This Agreement
shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or
unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible that is valid and enforceable. 

8.7 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, and all of which
taken together shall constitute one and the same instrument. 
 8.8 Entire Agreement. This Agreement (including all agreements
entered into pursuant hereto and all certificates and instruments delivered pursuant hereto and thereto) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous agreements,
representations, understandings, negotiations and discussions between the parties, whether oral or written, including, without limitation the Prior Agreement. 

[Signature Page Follows] 

  
 26 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock-Up Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 

 

			
	DYNAMICS SPECIAL PURPOSE CORP.
		
	By:	 	/s/ Mostafa Ronaghi
	Name:	 	Mostafa Ronaghi
	Title:	 	Chief Executive Officer

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Dynamics Group, LLC
	
	/s/ Omid Farokhzad
	Name: Omid Farokhzad
	Title: Sole Member

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Mostafa Ronaghi
	Mostafa Ronaghi

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Mark Afrasiabi
	Mark Afrasiabi

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Rowan Chapman
	Rowan Chapman

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Jay Flatley
	Jay Flatley

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ David Epstein
	David Epstein

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Dipchand Nishar
	Dipchand Nishar

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Robert Langer
	Robert Langer

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	EQ Advisors Trust – EQ/Morgan Stanley Small Cap Growth Portfolio, by Morgan Stanley Investment Management Inc., its sub-adviser
	
	/s/ Jason Yeung
	Name: Jason Yeung
	Title: Managing Director

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Morgan Stanley Investment Funds – Counterpoint Global Fund, by Morgan Stanley Investment Management Inc., its investment adviser
	
	/s/ Jason Yeung
	Name: Jason Yeung
	Title: Managing Director

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Morgan Stanley Institutional Fund Inc –
	Counterpoint Global Portfolio, by Morgan Stanley Investment Management Inc., its investment adviser
	
	/s/ Jason Yeung
	Name: Jason Yeung
	Title: Managing Director

  

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Morgan Stanley Institutional Fund Inc – Inception Portfolio, by Morgan Stanley Investment Management Inc., its investment adviser
	
	/s/ Jason Yeung
	Name: Jason Yeung
	Title: Managing Director

  

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Inception Trust, by Morgan Stanley Investment Management Inc., its investment manager
	
	/s/ Jason Yeung
	Name: Jason Yeung
	Title: Managing Director

  

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTORS:
	
	Bank of America Pension Plan
	DOW RETIREMENT GROUP TRUST – SCG
	MassMutual Select Funds – MassMutual
	Select T. Rowe Price Small and Mid Cap Blend
	Fund
	New York City Deferred Compensation Plan
	PFIZER MASTER TRUST
	Saint-Gobain Corporation
	T. Rowe Price Health Sciences Fund, Inc.
	T. Rowe Price Health Sciences Portfolio
	T. Rowe Price New Horizons Fund, Inc.
	T. Rowe Price New Horizons Trust
	T. Rowe Price U.S. Equities Trust
	TD Mutual Funds – TD Health Sciences Fund
	
	Each account, severally and not jointly
	
	By: T. Rowe Price Associates, Inc., Investment
	
	Adviser or Subadviser, as applicable
	
	/s/ Andrew Baek
	Name: Andrew Baek
	Title: Vice President, Senior Legal Counsel

  

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	ARK Investment Management LLC
	
	/s/ Kellen Carter
	Name: Kellen Carter
	Title: Corporate Counsel

  

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	 INVESTOR:

	
	 Invus Public Equities, L.P.

	
	 /s/ Khalil Barrage

	 Name: Khalil Barrage

	Title: VP of the General Partner

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	C. and E. Herberts Revocable Trust dtd July 17, 2013
	
	/s/ Curt Herberts
	Name: Curt Herberts
	Title: Co- Trustee
	
	C. and E. Herberts Revocable Trust dtd July 17, 2013
	
	/s/ Evan Kanaly Herberts
	Name: Evan Kanaly Herberts
	Title: Co- Trustee

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	 INVESTOR:

	
	 /s/ Deborah Knobelman

	Deborah Knobelman

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	 INVESTOR:

	
	 Luminen Services, LLC, as Trustee

	
	 /s/ Paul Mower

	 Name: Paul Mower

	 Title: One of its Managers

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	 INVESTORS:

	
	 NEA Ventures 2018, L.P.

	
	 /s/ Louis Citron

	 Name: Louis Citron

	 Title: Chief Legal Officer

	
	 New Enterprise Associates 15, L.P.

	
	 /s/ Louis Citron

	 Name: Louis Citron

	Title: Chief Legal Officer

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ James J. Collins
	James J. Collins

  

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Sandy Shan Wang
	Sandy Shan Wang

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTORS:
	
	8VC ENTREPRENEURS FUND I, L.P.
	By: 8VC GP I, LLC
	Its General Partner
	
	/s/ Ian M. Shannon
	Name: Ian M. Shannon
	Title: Authorized Signatory
	
	8VC FUND I, L.P.
	By: 8VC GP I, LLC
	Its General Partner
	
	/s/ Ian M. Shannon
	Name: Ian M. Shannon
	Title: Authorized Signatory

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Bayer HealthCare LLC
	
	/s/ Kelly Gast
	Name: Kelly Gast
	Title: President

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	Matrix Partners China VI Hong Kong Limited
	
	/s/ Ran Geng
	Name: Ran Geng
	Title: Vice President

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Timothy Lu
	Timothy Lu

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have caused this Investor Rights and Lock Up
Agreement to be executed and delivered by their duly authorized representatives as of the date first written above. 
  

	
	INVESTOR:
	
	/s/ Philip Lee
	Philip Lee

  
 SIGNATURE
PAGE TO INVESTOR RIGHTS AGREEMENT 

 EXHIBIT A 

Addendum Agreement 
 This
Addendum Agreement (“Addendum Agreement”) is executed on __________________, 20___, by the undersigned (the “New Holder”) pursuant to the terms of that certain Investor Rights and
Lock-Up Agreement dated as of June 8, 2022 (the “Agreement”), by and among the Company and the Investors identified therein, as such Agreement may be amended, supplemented or otherwise
modified from time to time. Capitalized terms used but not defined in this Addendum Agreement shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Addendum Agreement, the New Holder agrees as follows:

 1. Acknowledgment. New Holder acknowledges that New Holder is acquiring certain shares of common stock of the Company (the
“Class A Common Stock”) as a transferee of such shares of Class A Common Stock from a party in such party’s capacity as a holder of Registrable Securities under the Agreement, and after such transfer,
New Holder shall be considered an “Investor” and a holder of Registrable Securities for all purposes under the Agreement. 
 2.
Agreement. New Holder hereby (a) agrees that the shares of Class A Common Stock shall be bound by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and effect as if the New Holder were
originally a party thereto. 
 3. Notice. Any notice required or permitted by the Agreement shall be given to New Holder at the
address or facsimile number listed below New Holder’s signature below. 
  

							
	NEW HOLDER:	 		 	ACCEPTED AND AGREED:
			
	Print Name:                                   
                                         
    	 		 	DYNAMICS SPECIAL PURPOSE CORP.
				
	By:                                     
                                         
              	 		 	By:	 	 
		 		 		 	Name: Mostafa Ronaghi
		 		 		 	Title: Chief Executive Officer

  
 55 

 SCHEDULE I 

DYNS Investors 
 Dynamics Group, LLC 

Mostafa Ronaghi 
 Mark Afrasiabi 

Rowan Chapman 
 Jay Flatley 

David Epstein 
 Deep Nishar 

Bob Langer 
 EQ Advisors Trust – EQ/Morgan Stanley Small Cap
Growth Portfolio 
 Morgan Stanley Investment Funds, Inc. – Counterpoint Global Fund 

Morgan Stanley Institutional Fund, Inc. – Counterpoint Global Portfolio 

Morgan Stanley Institutional Fund, Inc. – Inception Portfolio 

Inception Trust 
 Bank of America Pension Plan 

DOW Retirement Group Trust – SCG 
 MassMutual Select Funds
– MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund 
 New York City Deferred Compensation Plan 

Pfizer Master Trust 
 Saint-Gobain Corporation 

T. Rowe Price Health Sciences Fund, Inc. 
 T. Rowe Price Health
Sciences Portfolio 
 T. Rowe Price New Horizons Fund, Inc. 
 T.
Rowe Price New Horizons Trust 
 T. Rowe Price U.S. Equities Trust 

TD Mutual Funds – TD Health Sciences Fund 
 ARK Investment
Management LLC 
 Invus Public Equities, L.P. 
 Senti
Investors 
 C. and E. Herberts Revocable Trust dtd July 17, 2013 

Deborah Knobelman 
 Luminen Services, LLC 

NEA Ventures 2018, L.P. 
 New Enterprise Associates 15, L.P. 

James J. Collins 
 Sandy Shan Wang 

8VC Entrepreneurs Fund I, L.P. 
 8VC Fund I, L.P. 

Bayer HealthCare LLC 
 Matrix Partners China VI Hong Kong Limited

 Timothy Lu 
 Philip Lee 

 SCHEDULE II 

Investors by Lock-Up 

1-year lockup 

Dynamics Group, LLC 
 Mostafa Ronaghi 

Mark Afrasiabi 
 Rowan Chapman 

Jay Flatley 
 David Epstein 

Deep Nishar 
 Bob Langer 

C. and E. Herberts Revocable Trust dtd July 17, 2013 

Deborah Knobelman 
 Luminen Services, LLC 

NEA Ventures 2018, L.P. 
 New Enterprise Associates 15, L.P. 

James J. Collins 
 Sandy Shan Wang 

8VC Entrepreneurs Fund I, L.P. 
 8VC Fund I, L.P. 

EQ Advisors Trust – EQ/Morgan Stanley Small Cap Growth Portfolio 

Morgan Stanley Investment Funds, Inc. – Counterpoint Global Fund 

Morgan Stanley Institutional Fund, Inc. – Counterpoint Global Portfolio 

Morgan Stanley Institutional Fund, Inc. – Inception Portfolio 

Inception Trust 
 Bank of America Pension Plan 

DOW Retirement Group Trust – SCG 
 MassMutual Select Funds
– MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund 
 New York City Deferred Compensation Plan 

Pfizer Master Trust 
 Saint-Gobain Corporation 

T. Rowe Price Health Sciences Fund, Inc. 
 T. Rowe Price Health
Sciences Portfolio 
 T. Rowe Price New Horizons Fund, Inc. 
 T.
Rowe Price New Horizons Trust 
 T. Rowe Price U.S. Equities Trust 

TD Mutual Funds – TD Health Sciences Fund 
 ARK Investment
Management LLC 
 Invus Public Equities, L.P. 

 18-month lockup 

Matrix Partners China VI Hong Kong Limited 
 Mirae Asset Capital,
Inc. 
 Mirae Asset-Celltrion New Growth Fund I 
 Mirae
Asset-Naver New Growth Fund I 
 3-year lockup 

Timothy Lu 
 Philip LeeDocument

Pear Therapeutics, Inc.
Severance And Change In Control Plan
Section 1.  Introduction and Purpose. 
The Pear Therapeutics, Inc. Severance and Change in Control Plan (the “Plan”) is hereby established by the Board of Directors of Pear Therapeutics, Inc. (the “Company”) effective as of June 14, 2022. The purpose of the Plan is to provide for the payment of severance and/or Change in Control (as defined below) benefits to eligible employees of the Company and its Affiliates (as defined below).  The Plan is intended to be (i) an employee welfare benefit plan within the meaning of Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and (ii) a “top hat” plan within the meaning of Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA. This Plan document also is the Summary Plan Description for the Plan.   
For purposes of the Plan, the following terms are defined as follows: 
(a)“Affiliate” means any corporation (other than the Company) in an “unbroken chain of corporations” beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 
(b)“Base Salary” means base pay (excluding incentive pay, premium pay, commissions, overtime, bonuses and other forms of variable compensation) as in effect immediately prior to any reduction that would give rise to an employee’s right to a resignation for Good Reason (if applicable). 
(c)“Cause” means, with respect to an Eligible Employee, (a) any material breach of any agreement to which the Eligible Employee and the Company, or an Affiliate as applicable, are both parties, (b) any act (other than retirement) or omission to act by the Eligible Employee which may have a material and adverse effect on the business of the Company and/or any of its Affiliates, or on the Eligible Employee’s ability to perform services for the Company or an Affiliate, including, without limitation, the commission of any crime (other than minor traffic violations), or (c) any material misconduct or material neglect of duties by the Eligible Employee in connection with the business or affairs of the Company or an Affiliate. The employment of an Eligible Employee will be deemed to have been terminated for Cause if the Plan Administrator determines within thirty (30) days of the termination of employment (whether such termination was voluntary or involuntary) that termination for Cause was warranted. The determination whether a termination is for Cause shall be made by the Plan Administrator in its sole and exclusive judgment and discretion.
(d)“Change in Control” has the meaning ascribed to the term “Sale Event” in the Equity Plan, provided that the event qualifies as a change in the ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each within the meaning of Section 409A. 
(e)“Change in Control Date” means the closing date of a Change in Control.  
(f)“Change in Control Period” means the period commencing sixty (60) days prior to the Change in Control Date and ending 12 months following such date. 
(g) “Code” means the Internal Revenue Code of 1986, as amended. 

 

(h)“Committee” means the Board of Directors of the Company or the Compensation Committee of such Board of Directors. 
(i)“Common Stock” means the Class A common stock, par value $0.0001 per share, of the Company.
(j)“Company” means Pear Therapeutics, Inc. or, following a Change in Control, the surviving entity resulting from such event (such entity, the “Successor Entity”). 
(k)“Covered Termination” means, with respect to an Eligible Employee, a termination of employment that results in such employee’s Separation from Service that is due to (i) a termination by the Company or an Affiliate without Cause (and other than as a result of death or Disability) or (ii) a resignation by the Eligible Employee for Good Reason. 
(l)“Disability” means any physical or mental condition that renders an employee incapable of performing the work for which he or she was employed by the Company or similar work offered by the Company or an Affiliate. The Disability of an employee shall be established if (i) the employee satisfies the requirements for benefits under the Company’s long-term disability plan of the Company or an Affiliate or (ii) if no long-term disability plan, the employee satisfies the requirements for Social Security disability benefits. 
(m)“Eligible Employee” means an employee of the Company or an Affiliate that meets the requirements to be eligible to receive Plan benefits as set forth in Section 2. 
(n)“Equity Plan” means the Company’s 2021 Stock Option and Incentive Plan, as amended from time to time, or any successor plan thereto. 
(o)“Good Reason” for an employee’s resignation means the occurrence of any of the following that is undertaken by the Company or an Affiliate without the employee’s prior written consent: 
(i)a material reduction in such employee’s base salary or target annual bonus (unless pursuant to a proportional reduction program applicable generally to similarly situated employees of the Company or Affiliate); 
(ii)a material reduction in such employee’s position, duties or responsibilities or any assignment to such employee of duties or responsibilities that are materially inconsistent in an adverse respect with such employee’s position (other than a change that is solely as a result of the Company transitioning from being publicly traded to privately held); or  
(iii)a relocation of such employee’s principal place of employment with the Company or Affiliate (or Successor Entity, if applicable) to a place that is more than twenty-five (25) miles from the employee’s prior work location and which increases such employee’s commute from the employee’s principal residence.
Notwithstanding the foregoing, in order for the employee’s resignation to be deemed to have been for Good Reason, the employee must provide written notice to the Company or Affiliate, as applicable, of such employee’s intent to resign for Good Reason within 30 days after the first occurrence of the event giving rise to Good Reason, which notice shall describe the event(s) the employee believes give rise to Good Reason; allow the Company or Affiliate 30 days from receipt of the written notice to cure the event (such period, the “Cure Period”); and if the event is 
2

 

not reasonably cured within the Cure Period, the employee’s resignation from all positions held with the Company or Affiliate is effective not later than 30 days after the expiration of the Cure Period. 
(p)“New Employee” means an Eligible Employee for whom a Covered Termination occurs prior to such employee’s one year anniversary of employment with the Company or an Affiliate, as applicable.
(q)“Plan Administrator” means the Committee prior to the Change in Control Date and the Representative upon and following such date, as applicable. 
(r)“Plan Tier” means the tier to which an Eligible Employee is assigned for purposes of participation in the Plan, as determined by the individual or entity that sets the Eligible Employee’s compensation, as set forth in the Eligible Employee’s Participation Notice (as described in Section 2(a)). 
(s)“Representative” means one or more members of the Committee or other persons or entities designated by the Committee prior to or in connection with a Change in Control that will have authority to administer and interpret the Plan upon and following the Change in Control Date as provided in Section 11. 
(t)“Section 409A” means Section 409A of the Code and the treasury regulations and other guidance thereunder and any state law of similar effect. 
(u)“Separation from Service” means a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h). 
Section 2.  Eligibility for Benefits. 
(a)Eligible Employee. An employee of the Company or an Affiliate is eligible to participate in the Plan if (i) the employee has the title of Vice President or higher or has otherwise been designated by the Plan Administrator as eligible to participate; (ii) such employee is designated as an Eligible Employee by the Plan Administrator through a Participation Notice in the form attached hereto as Exhibit A (which will specify the employee’s Plan Tier); (iii) the employee has signed and returned the Participation Notice provided by the Plan Administrator; and (iv) the employee meets the other Plan eligibility requirements set forth in this Section 2. The determination of whether an employee is an Eligible Employee shall be made by the Plan Administrator, in its sole discretion, and such determination shall be binding and conclusive on all persons. 
(b)Release Requirement. In order to be eligible to receive benefits under the Plan, the employee also must execute a general waiver and release in the form attached hereto as Exhibit B  (the “Release”), within the applicable time period set forth therein, and such Release must become effective in accordance with its terms, which must occur in no event more than 60 days following the date of the applicable Covered Termination. If an employee does not provide a Release that becomes effective as set forth above, no payments shall be made to such employee under the Plan, and the employee will have no further right to any benefits under the Plan.
(c)Plan Benefits Provided In Lieu of Any Previous Benefits. This Plan shall supersede any change in control or severance benefit plan, policy or practice previously maintained by the Company or an Affiliate with respect to an Eligible Employee and any change in control or severance benefits in any individually negotiated employment contract or other agreement between the Company or an Affiliate and an Eligible Employee, including but not 
3

 

limited to any Management Retention Agreement between the Eligible Employee and the Company. Notwithstanding the foregoing, the Eligible Employee’s equity awards will remain subject to the terms and conditions of the applicable equity plan under which such awards were granted and no provision of this Plan shall be construed as to limit the actions that may be taken under, or to violate the terms of, such equity plan. 
(d)Exceptions to Severance Benefit Entitlement. An employee who otherwise is an Eligible Employee shall not receive benefits under the Plan in the following circumstances, as determined by the Plan Administrator in its sole discretion: 
(1)The employee is terminated by the Company or an Affiliate for any reason (including due to the employee’s death or Disability) or voluntarily terminates employment with the Company in any manner, and in either case, such termination does not constitute a Covered Termination. Voluntary terminations include, but are not limited to, resignation, retirement or failure to return from a leave of absence on the scheduled date. 
(2)The employee is offered immediate reemployment by a Successor Entity following a Change in Control and the terms of such reemployment would not give rise to the employee’s right to a resignation for Good Reason. For purposes of the foregoing, “immediate reemployment” means that the employee’s employment with Successor Entity results in uninterrupted employment such that the employee does not incur a lapse in pay or benefits as a result of the Change in Control. For the avoidance of doubt, an employee who becomes immediately reemployed by a Successor Entity following a Change in Control will continue to be an Eligible Employee following the date of such reemployment. 
(3)The employee is rehired by the Company or an Affiliate and recommences employment prior to the date severance benefits under the Plan are scheduled to commence. 
(e)Termination of Severance Benefits. An Eligible Employee’s right to receive severance benefits under this Plan shall terminate immediately if, at any time prior to or during the period for which the Eligible Employee is receiving severance benefits under the Plan, the Eligible Employee willfully breaches any material statutory, common law, or contractual obligation to the Company or an Affiliate (including, without limitation, the contractual obligations set forth in any confidentiality, non-disclosure and developments agreement, non-competition, non-solicitation, return of Company property or similar type agreement between the Eligible Employee and the Company, as applicable).
Section 3.  Termination Benefits Generally. 
Upon the termination of an Eligible Employee’s employment for any reason, the Eligible Employee will be entitled to receive (i) any earned but unpaid base salary and (ii) any vested employee benefits in accordance with the terms of the applicable employee benefit plan or program (the “Accrued Benefits”). In addition, in the event of a Covered Termination, the Eligible Employee may be eligible to receive additional payments and benefits, as set forth in Section 4 or Section 5 below, as applicable. 
Section 4.  Benefits for Covered Termination Outside of a Change in Control Period; Benefits for New Employees for Covered Termination at any Time. 
(a)Covered Termination. If an Eligible Employee (other than a New Employee) experiences a Covered Termination at any time other than during the Change in Control Period, or a New Employee experiences a Covered Termination at any time, the Eligible Employee will be entitled to receive the following severance benefits: 
4

 

(1)Base Salary. An Eligible Employee, who is not a New Employee, will receive a cash severance payment equal to the Eligible Employee’s Base Salary for the following number of months (such number of months, the “Severance Period” for that Eligible Employee), depending on the Eligible Employee’s Plan Tier: 
(i)Tier 1:     18 months 
(ii)Tier 2(a):     15 months 
(iii)Tier 2(b):     12 months 
(iv)Tier 3:         9 months 
For an Eligible Employee who is a New Employee, the Severance Period will be six (6) months, regardless of such employee’s Plan Tier.
The cash severance payment shall be paid in the form of salary continuation over the course of the Severance Period, on the  regular payroll dates of the Company or Affiliate as applicable, subject to deductions and withholdings; provided however that no payment will be paid prior to the effective date of the Release. 
(2)Payment of Continued Group Health Plan Benefits. If the Eligible Employee is eligible for and timely elects to continue health insurance coverage under the Company’s group health plans under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) following the Covered Termination date, the Company will pay the COBRA group health insurance premiums (as such premiums are due) for the Eligible Employee and the Eligible Employee’s eligible dependents until the earliest of (A) the end of the Severance Period, (B) the expiration of the Eligible Employee’s eligibility for the continuation coverage under COBRA, or (C) the date when the Eligible Employee becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment. Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that it cannot pay the COBRA premiums without potentially incurring financial costs or penalties under applicable law, then in lieu of providing the COBRA premiums, the Company will instead pay the Eligible Employee on the last day of each remaining month of the Severance Period, a fully taxable cash payment equal to the COBRA premiums for that month, subject to applicable tax withholdings.
(b)No Other Payments.  The benefits set forth at subsections (a)(1) and (a)(2) above are the only benefits payable to an Eligible Employee (other than a New Employee) pursuant to the Plan with respect to a Covered Termination that occurs outside of a Change in Control Period, or payable to a New Employee with respect to a Covered Termination that occurs at any time.  
Section 5.  Covered Termination Benefits (during a Change in Control Period). 
(a)Covered Termination. If an Eligible Employee (other than a New Employee) experiences a Covered Termination during a Change in Control Period, such Eligible Employee will be entitled to receive the following severance benefits: 
(1)Base Salary. The Eligible Employee will receive a cash severance payment equal to the Eligible Employee’s Base Salary for the following number of months (such number of months, the “Change in Control Severance Period” for that Eligible Employee), depending on the Eligible Employee’s Plan Tier: 
5

 

(i)Tier 1:         24 months 
(ii)Tier 2(a):     18 months 
(iii)Tier 2(b):     15 months 
(iv)Tier 3:         12 months 
Such cash severance benefit shall be paid in a single lump payment no later than the second payroll cycle following the later of (i) the effective date of the Release or (ii) the Change in Control Date, but in any event not later than March 15 of the year following the year in which the Covered Termination occurs. 
Notwithstanding the foregoing, in the event of a Covered Termination that occurs within the sixty (60) day period prior to the Change in Control Date, the amount payable pursuant to this Section 5(a)(1) shall be reduced by any amounts previously paid pursuant to Section 4(a)(1) above, and the net cash severance benefit shall be paid as set forth in this Section 5(a)(1).  
(2)Payment of Continued Group Health Plan Benefits. During the Change in Control Severance Period, the Eligible Employee will be eligible to receive the payments described in, and pursuant to the terms of, Section 4(a)(2) above; provided however that in the event of a Covered Termination that occurs within the sixty (60) day period prior to the Change in Control Date, the Change in Control Severance Period will be reduced by the number of months, if any, for which COBRA payments were made pursuant to Section 4(a)(2) above.   
(3)Target Bonus Payment. The Eligible Employee will receive a lump sum cash payment equal to a percentage of the Eligible Employee’s target annual bonus amount for the calendar year in which the Covered Termination occurs (which for the avoidance of doubt will not be pro-rated), depending on their Plan Tier: 
(i)Tier 1:         200% of target annual bonus 
(ii)Tier 2(a):     150% of target annual bonus 
(iii)Tier 2(a):     125% of target annual bonus 
(iv)Tier 3:         100% of target annual bonus 
This payment shall be paid to the Eligible Employee in a lump sum cash payment on the same date as the Base Salary payment provided in subsection 5(a)(1) above. 
(4)Equity Acceleration. The vesting and exercisability of each outstanding unvested stock option and other stock awards, as applicable, held by the Eligible Employee covering Common Stock as of the date of the Covered Termination (each, an “Equity Award”) that vest solely based on continued service with the Company over time will be accelerated in full and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to any such time-vesting Equity Award will lapse in full. Equity Awards subject to vesting based on the attainment of performance goals will not be subject to acceleration, except as determined by the Committee in its sole discretion either pursuant to the Plan or pursuant to Section 3(c) of the Equity Plan. To the extent an Equity Award is assumed, continued or substituted for in a Change in Control pursuant to such applicable equity incentive plan, the vesting acceleration described in this Section 5(a)(4) will apply to such assumed, continued or substituted award, as applicable. 
6

 

(b)No Duplication of Benefits. The benefits set forth at subsections (a)(1) through (a)(4) above are the only benefits payable to an Eligible Employee (other than a New Employee) pursuant to the Plan with respect to a Covered Termination that occurs during a Change in Control Period, and shall be paid in lieu of any benefits that may be payable pursuant to Section 4 above with respect to a Covered Termination that occurs outside of a Change in Control Period.  For the avoidance of doubt, in no event will benefits be provided under both Section 4 and Section 5 to the same Eligible Employee (except to the extent that benefits were provided pursuant to Section 4 with respect to a Covered Termination that occurred during the sixty (60) day period prior to a Change in Control Date, in which case the benefits provided pursuant to Sections 5(a)(1) and 5(a)(2) will be adjusted as set forth above). 
Section 6.  Section 280G Limitation. 
Notwithstanding anything in the Plan to the contrary, if any payment or benefit an Eligible Employee will or may receive from the Company or an Affiliate or otherwise (each payment or benefit, a “Payment,” and in the aggregate, the “Payments”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Payments shall be reduced (but not below zero) so that the sum of the Payments will be $1.00 less than the amount at which the Eligible Employee becomes subject to the Excise Tax; provided that such reduction will only occur if it would result in the Eligible Employee receiving a higher After Tax Amount (as defined below) than the Eligible Employee would receive absent such reduction. In the event of such reduction, the Payments will be reduced in the following order, in each case, in reverse chronological order beginning with the Payments that are to be paid the furthest in time from consummation of the transaction that is subject to Section 280G of the Code: (1) cash payments not subject to Section 409A; (2) cash payments subject to Section 409A; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits; provided that in the case of all the foregoing Payments all amounts or payments that are not subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c) will be reduced before any amounts that are subject to calculation under Treas. Reg. §1.280G-1, Q&A-24(b) or (c).
For purposes of this Section 6, the term “After Tax Amount” means the amount of the Payments less all federal, state, and local income, excise and employment taxes imposed on the Eligible Employee as a result of the Eligible Employee’s receipt of the Payments. For purposes of determining the After Tax Amount, the Eligible Employee will be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes (if any) which could be obtained from deduction of such state and local taxes.
The determination as to whether a reduction in the Payments will be made pursuant to this Section 6 shall be made by the Company in consultation with its external advisers, and the Company shall provide detailed supporting calculations to the Eligible Employee within fifteen (15) business days of the Eligible Employee’s Covered Termination.  
Section 7.  Withholding. 
All payments under the Plan will be subject to applicable withholding for federal, state, foreign, and local taxes.
Section 8.  Section 409A. 
7

 

All benefits provided under the Plan are intended to be exempt from the requirements of Section 409A to the maximum extent possible and any ambiguities herein shall be interpreted accordingly; provided, however, that to the extent that any benefits are not so exempt, such benefits are intended to comply with the requirements of Section 409A and any ambiguities herein shall be interpreted accordingly. It is intended that each installment of benefits payable to an Eligible Employee be regarded as a separate “payment” for purposes of Treasury Regulations Section 1.409A-2(b)(2)(i).  
If the Company determines that any benefits payable under the Plan constitute “deferred compensation” under Section 409A and the Eligible Employee is a “specified employee” of the Company, as such term is defined in Section 409A, then, to the extent necessary to avoid the imposition of the adverse tax consequences under Section 409A, the timing of such benefit payments shall be delayed until the earlier of (1) the date that is six months and one day after the Eligible Employee’s Separation from Service and (2) the date of the Eligible Employee’s death.  In the event of such delayed payment, the Company shall then pay the Eligible Employee a lump sum amount equal to the sum of the severance benefit payments that would otherwise have been paid prior to the delay and pay any remaining amounts of severance benefits in accordance with the applicable payment schedule. 
In no event will payment of any benefits under the Plan be made prior to an Eligible Employee’s Separation from Service or prior to the effective date of the Release. If the Company determines that any benefits provided under the Plan constitute “deferred compensation” under Section 409A, and the period for providing a Release set forth at Section 2(b) above spans two calendar years, then regardless of when the Release is returned to the Company and becomes effective, the Release will not be deemed effective, solely for purposes of the timing of payment of benefits under this Plan, until the later of the day that it would become effective under its terms or the first day of the latter calendar year. 
Notwithstanding the foregoing, the Company makes no representation or warranty and will have no liability to the Eligible Employee or any other person if any provisions of this Plan are determined to constitute deferred compensation subject to Section 409A but do not satisfy an exemption from, or the conditions of, Section 409A.
Section 9.  Transfer and Assignment. 
The rights and obligations of an Eligible Employee under this Plan may not be transferred or assigned. The Plan shall be binding upon any entity or person who is a successor by merger, acquisition, consolidation or otherwise to the business formerly carried on by the Company without regard to whether or not such entity or person actively assumes the obligations hereunder and without regard to whether or not a Change in Control occurs. 
Section 10.  Clawback.
All payments and severance benefits provided under the Plan shall be subject to recoupment in accordance with any clawback policy of the Company, as in effect from time to time.
Section 11.  Right to Interpret and Administer Plan; Amendment and Termination. 
(a)Interpretation and Administration. Prior to a Change in Control, the Committee shall be the Plan Administrator and will have the exclusive discretion and authority to establish rules, forms, and procedures for the administration of the Plan and to construe and interpret the Plan and to decide any and all questions of fact, interpretation, definition, 
8

 

computation or administration arising in connection with the operation of the Plan, including, but not limited to, the eligibility to participate in the Plan and amount of benefits paid under the Plan. The rules, interpretations, computations and other actions of the Committee shall be binding and conclusive on all persons. Upon and after the Change in Control Date, the Plan will be interpreted and administered in good faith by the Representative who shall be the Plan Administrator during such period. All actions taken by the Representative in interpreting the terms of the Plan and administering the Plan upon and after the Change in Control Date will be final and binding on all Eligible Employees. Any references in this Plan to the “Committee” or “Plan Administrator” with respect to periods following such date shall mean the Representative. 
(b)Amendment. The Plan Administrator reserves the right to amend or terminate this Plan at any time; provided however that no such amendment or termination shall materially and adversely affect the rights of any Eligible Employee who has satisfied the requirements of Section 2(a) without the consent of such Eligible Employee  
(c)Termination. Unless otherwise extended by the Committee, the Plan will automatically terminate following satisfaction of all the Company’s obligations under the Plan. 
Section 12.  No Implied Employment Contract. 
The Plan shall not be deemed (i) to give any employee or other person any right to be retained in the employ of the Company or a Successor Entity, as applicable, or (ii) to interfere with the right of the Company or a Successor Entity, as applicable, to discharge any employee or other person at any time, with or without cause, which right is hereby reserved. This Plan does not modify the at-will employment status of any Eligible Employee. 
Section 13.  Plan is Unfunded. 
The Plan shall be unfunded, and all cash payments under the Plan paid only from the general assets of the Company. 
Section 14.  Governing Law. 
This Plan is intended to be governed by and shall be construed in accordance with ERISA and, to the extent not preempted by ERISA, the laws of the State of Delaware.  
Section 15.  Claims, Inquiries and Appeals. 
(a)Applications for Benefits and Inquiries. Any application for benefits, inquiries about the Plan or inquiries about present or future rights under the Plan must be submitted to the Plan Administrator in writing by an applicant (or his or her authorized representative). 
(b)Denial of Claims. In the event that any application for benefits is denied in whole or in part, the Plan Administrator must provide the applicant with written or electronic notice of the denial of the application, and of the applicant’s right to review the denial. Any electronic notice will comply with the regulations of the U.S. Department of Labor. The notice of denial will be set forth in a manner designed to be understood by the applicant and will include the following: (i) the specific reason or reasons for the denial; (ii) references to the specific Plan provisions upon which the denial is based; (iii) a description of any additional information or material that the Plan Administrator needs to complete the review and an explanation of why such information or material is necessary; and (iv) an explanation of the Plan’s review procedures and the time limits applicable to such procedures, including a statement of the applicant’s right to bring a civil action under Section 502(a) of ERISA following a denial on 
9

 

review of the claim.  This notice of denial will be given to the applicant within 90 days after the Plan Administrator receives the application, unless special circumstances require an extension of time, in which case, the Plan Administrator has up to an additional 90 days for processing the application. If an extension of time for processing is required, written notice of the extension will be furnished to the applicant before the end of the initial 90-day period, describing the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render its decision on the application. 
(c)Request for a Review. Any person (or that person’s authorized representative) for whom an application for benefits is denied, in whole or in part, may appeal the denial by submitting a request for a review to the Plan Administrator within 60 days after the application is denied. A request for review must set forth all of the grounds on which it is based, all facts in support of the request and any other matters that the applicant feels are pertinent. The applicant (or his or her representative) will have the opportunity to submit (or the Plan Administrator may require the applicant to submit) written comments, documents, records, and other information relating to his or her claim. The applicant (or his or her representative) shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to his or her claim. The review will take into account all comments, documents, records and other information submitted by the applicant (or his or her representative) relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. 
(d)Decision on Review. The Plan Administrator will act on each request for review within 60 days after receipt of the request, unless special circumstances require an extension of time (not to exceed an additional 60 days), for processing the request for a review. If an extension for review is required, written notice of the extension will be furnished to the applicant within the initial 60-day period. This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render its decision on the review. The Plan Administrator will give prompt, written or electronic notice of its decision to the applicant. Any electronic notice will comply with the regulations of the U.S. Department of Labor. In the event that the Plan Administrator confirms the denial of the application for benefits in whole or in part, the notice will set forth, in a manner calculated to be understood by the applicant, the following: (ii) the specific reason or reasons for the denial; (ii) references to the specific Plan provisions upon which the denial is based; (iii) a statement that the applicant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to his or her claim; and (iv) a statement of the applicant’s right to bring a civil action under Section 502(a) of ERISA. 
(e)Rules and Procedures. The Plan Administrator will establish rules and procedures, consistent with the Plan and with ERISA, as necessary and appropriate in carrying out its responsibilities in reviewing benefit claims. The Plan Administrator may require an applicant who wishes to submit additional information in connection with an appeal from the denial of benefits to do so at the applicant’s own expense. 
(f)Exhaustion of Remedies. No legal action for benefits under the Plan may be brought until the applicant (i) has submitted a written application for benefits in accordance with the procedures described by Section 15(a) above, (ii) has been notified by the Plan Administrator that the application is denied, (iii) has filed a written request for a review of the application in accordance with the appeal procedure described in Section 15(c) above, and (iv) has been notified that the Plan Administrator has denied the appeal. Notwithstanding the foregoing, if the Plan Administrator does not respond to an Eligible Employee’s claim or appeal within the relevant time limits specified in this Section 15, the Eligible Employee may bring legal action for benefits under the Plan pursuant to Section 502(a) of ERISA. 
10

 

Section 16.  Other Plan Information. 
Employer Identification Number:  85-4103092
Plan Number:  503
Plan Year: The Plan is maintained on a calendar year (January 1 – December 31). 
Plan Administrator:  The Committee prior to the Change in Control Date, and the Representative upon and following such date.  
Agent for Service of Legal Process.   Ronan O’Brien, General Counsel, Pear Therapeutics, Inc., 200 State Street, 13th floor, Boston, MA 02109 
Section 17.  Statement of ERISA Rights. 
Participants in this Plan (which is a welfare benefit plan sponsored by Pear Therapeutics, Inc.) are entitled to certain rights and protections under ERISA. If you are an Eligible Employee, you are considered a participant in the Plan and, under ERISA, you are entitled to: 
(a)Receive Information About Your Plan and Benefits. This includes the right to (i) examine, without charge, at the Plan Administrator’s office and at other specified locations, such as worksites, all documents governing the Plan and a copy of the latest annual report (Form 5500 Series), if applicable, filed by the Plan with the U.S. Department of Labor and available at the Public Disclosure Room of the Employee Benefits Security Administration; (ii) obtain, upon written request to the Plan Administrator, copies of documents governing the operation of the Plan and copies of the latest annual report (Form 5500 Series), if applicable, and an updated (as necessary) Summary Plan Description (provided that a reasonable charge may be made for such copies; and (iii) receive a summary of the Plan’s annual financial report, if applicable. The Plan Administrator is required by law to furnish each Eligible Employee with a copy of this summary annual report. 
(b)Prudent Actions by Plan Fiduciaries. In addition to creating rights for employees eligible to participate in the Plan, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan. The people who operate the Plan, called “fiduciaries” of the Plan, have a duty to do so prudently and in the interest of you and other Eligible Employees and beneficiaries. No one, including your employer, your union or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a Plan benefit or exercising your rights under ERISA. 
(c)Enforce Your Rights. If your claim for a Plan benefit is denied or ignored, in whole or in part, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules.   Under ERISA, there are steps you can take to enforce the above rights. For instance, if you request a copy of Plan documents or the latest annual report from the Plan, if applicable, and do not receive them within 30 days, you may file suit in a Federal court. In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator.  If you have a claim for benefits which is denied or ignored, in whole or in part, you may file suit in a state or Federal court. If you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a Federal court. The court will decide who should pay court costs and legal fees. If you are successful, the court may order the person you have sued to pay these costs and fees. If 
11

 

you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous. 
(d)Assistance with Your Questions. If you have any questions about the Plan, you should contact the Plan Administrator. If you have any questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Plan Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210. You may also obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration. 

12

 

EXHIBIT A
Participation Notice

Name: ___________________ 
You have been designated as eligible to participate in the Pear Therapeutics, Inc. Severance and Change in Control Plan (the “Plan”), a copy of which is attached to this Participation Notice. 
You will receive the benefits set forth in the Plan if you meet all the eligibility requirements set forth in the Plan, including, without limitation, executing the required Release within the applicable time period set forth therein and allowing such Release to become effective in accordance with its terms. 
If you are a party to a Management Retention Agreement with the Company, by signing below, you hereby terminate such Management Retention Agreement and irrevocably forfeit any right to benefits set forth therein, and you understand and agree that such Management Retention Agreement shall be of no further force or effect as of the date set forth below. 
Your Plan Tier has been designated as: Tier __ 
To accept the terms of this Participation Notice and participate in the Plan, please sign and date this Participation Notice in the space provided below and return it to _____________________ no later than _________, ____. 
Eligible Employee

                    
[Insert Name]
Date:

13

 

EXHIBIT B
RELEASE OF CLAIMS 
This Release of Claims (“Release”) is entered into as of this ____ day of ______ 20___, by and between Pear Therapeutics, Inc., a Delaware corporation (the “Company”), and _________ (“You”). 
You and the Company agree as follows: 
 
1.    The employment relationship between You and the Company and its subsidiaries and affiliates, as applicable, terminated on _________, 20___ (the “Separation Date”). 
 
2.    In accordance with the Pear Therapeutics, Inc. Severance and Change in Control Plan, effective as of June 14, 2022 (the “Plan”), You are entitled to receive certain payments, rights and benefits after the Separation Date, subject to his execution, delivery and non-revocation of a general release of claims. 
 
3.    In consideration of the payments, rights and benefits provided for in the Plan, the sufficiency of which You hereby acknowledge, You, on behalf of yourself and your agents, representatives, attorneys, administrators, heirs, executors and assigns, hereby release and forever discharge each of the Company and all of its investors, parents, affiliates, subsidiaries, divisions, any and all current and former directors, officers, employees, agents, and contractors and their heirs and assigns, and any and all employee pension benefit or welfare benefit plans, if any, of the Company or any of its subsidiaries, including current and former trustees and administrators of such employee pension benefit and welfare benefit plans (the “Released Parties”), from all claims, charges or demands, in law or in equity, whether known or unknown, which may have existed or which may now exist from the beginning of time to the date of this Release, relating to any claims You may have arising from or relating to your employment or termination from employment with the Company or otherwise, including a release of any rights or claims You may have under Title VII of the Civil Rights Act of 1964, as amended, and the Civil Rights Act of 1991; the Americans with Disabilities Act of 1990, as amended, and the Rehabilitation Act of 1973; the Family and Medical Leave Act of 1993; Section 1981 of the Civil Rights Act of 1866; Section 1985(3) of the Civil Rights Act of 1871; the Executive Retirement Income Security Act of 1974, as amended; the Fair Labor Standards Act, as amended, 29 U.S.C. Section 201 et. seq.; the Massachusetts Fair Employment Practices Act (M.G.L.c. 151B); the Massachusetts Wage Act (M.G.L.c.149 et seq.); any other federal, state or local laws against discrimination; or any other federal, state, or local statute, regulation or common law relating to employment, wages, hours, or any other terms and conditions of employment. This includes a release by You of any and all claims or rights arising under contract (whether written or oral, express or implied), covenant, public policy, tort or otherwise. 
 
4.    You acknowledge that You are waiving and releasing any rights that You may have under the Age Discrimination in Employment Act of 1967, as amended (“ADEA”) and that this Release is knowing and voluntary. You and the Company agree that this Release does not apply to any rights or claims that may arise under the ADEA after the effective date of this Release. You acknowledge that the consideration given for this Release is in addition to anything of value to which You are already entitled. You further acknowledge that You have been advised by this writing that: (i) You should consult with an attorney prior to executing this Release; (ii) You have up to twenty-one (21) days within which to consider this Release, although You may, at your discretion, sign and return this Release at an earlier time in which case You waive all rights to the balance of this twenty-one (21) day review period; (iii) for a period of 7 days following the execution of this Release in duplicate originals You may revoke this Release in a writing 
14

 

delivered to the Chairman of the Board of the Company by hand or by mail (signature of receipt required), and this Release shall not become effective or enforceable until such 7-day revocation period has expired; and (iv) nothing in this Release prevents or precludes You from challenging or seeking a determination in good faith of the validity of this Release under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law. 
 
5.    You further acknowledge and agree that this RELEASE shall apply to all unknown and unanticipated injuries and/or damages. You acknowledge and understand that Section 1542 of the Civil Code of the State of California provides as follows: 
A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor. 
Being aware of Section 1542 of the California Civil Code, You, by signing this RELEASE, expressly waive the provisions of Section 1542 of the California Civil Code and any other similar provision of law that may be applicable. 
 
6.    This Release does not release the Released Parties from any obligations due to You under the Plan or under this Release. Without limiting the generality of the foregoing, the release set forth in Sections 4 and 5 does not and shall not extend to, and the undersigned is not releasing, (i) any claims enforcing the rights of the Plan and (ii) exculpatory or indemnification provisions set forth in the Certificate of Incorporation or Bylaws of the Company or available under the Delaware General Corporation Law, for the benefit of any individual who served as an officer or employee of the Company at any time prior to the Effective Date (the “Non-Released Claims”) that the undersigned may have or claim to have against any of the Released Parties, in each case whether currently known or unknown or with respect to which the facts are known (or should have been known), that could give rise to or support any Non-Released Claim and of every nature and extent whatsoever. In addition, nothing contained in this Release precludes You from filing a charge of discrimination with the United States Equal Employment Opportunity Commission (“EEOC”) or any state fair employment practices agency (“FEPA”) or participating in an investigation by the EEOC or any FEPA, but You will not be entitled to any monetary or other relief from the EEOC or any FEPA on the basis of or in connection with such charge or investigation, or from any Court as a result of litigation brought on the basis of or in connection with such charge or investigation. 
 
7.    This Release is not an admission by the Released Parties of any wrongdoing, liability or violation of law. 
 
8.    You waive any right to reinstatement or future employment with the Company following your termination from the Company. 

9.    You shall continue to be bound by the Employee Non-disclosure, Non-solicitation and Assignment of Intellectual Property Agreement between You and the Company. 
 
10.    You shall promptly return all property in your possession of Company and its subsidiaries and affiliates, including, but not limited to, keys, credit cards, computer equipment, software and peripherals and originals or copies of books, records, or other information pertaining to Company or its subsidiaries’ or affiliates’ businesses. 
 
11.    This Release shall be governed by the law of The Commonwealth of Massachusetts, without regard to its conflicts of laws rules. 
15

 

 
12.    This Release represents the complete agreement between You and the Company concerning the subject matter in this Release and supersedes all prior agreements or understandings, written or oral. This Release may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives. 
 
13.    Each of the sections contained in this Release shall be enforceable independently of every other section in this Release, and the invalidity or unenforceability of any section shall not invalidate or render unenforceable any other section contained in this Release. 
 
14.    You acknowledge that You have carefully read and understand this Release, that You have the right to consult an attorney with respect to its provisions and that this Release has been entered into voluntarily. You acknowledge that no representation, statement, promise, inducement, threat or suggestion has been made by any of the Released Parties to influence You to sign this Release except such statements as are expressly set forth herein or in the Separation Agreement. 
The parties to this Release have executed this Release as of the day and year first written above. 

																											
									
	PEAR THERAPEUTICS, INC.			 	YOU:

																											
									
				
	By:	 	 	 		 	 

																											
									
					
	Name:	 	 	 		 	Name:	 	 

																											
									
					
	Title:	 	 	 		 		 	

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]